{
  "genes": [
    {
      "geneSymbol": "ABCG2",
      "chr": "chr4",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [
        "rs2231142 reference (G)",
        "rs2231142 variant (T)"
      ],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "allopurinol",
          "id": "RxNorm:519"
        },
        {
          "name": "rosuvastatin",
          "id": "RxNorm:301542"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "ABCG2",
            "name": "Unknown",
            "function": "Unassigned function",
            "reference": false
          },
          "allele2": {
            "gene": "ABCG2",
            "name": "Unknown",
            "function": "Unassigned function",
            "reference": false
          },
          "gene": "ABCG2",
          "phenotypes": [
            "No Result"
          ],
          "variant": null,
          "lookupKey": [
            "No Result"
          ],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "ABCG2",
            "name": "Unknown",
            "function": "Unassigned function",
            "reference": false
          },
          "allele2": {
            "gene": "ABCG2",
            "name": "Unknown",
            "function": "Unassigned function",
            "reference": false
          },
          "gene": "ABCG2",
          "phenotypes": [
            "No Result"
          ],
          "variant": null,
          "lookupKey": [
            "No Result"
          ],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "ABCG2",
          "chromosome": "chr4",
          "position": 88131171,
          "dbSnpId": "rs2231142",
          "call": null,
          "alleles": [
            "rs2231142 variant (T)"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CACNA1S",
      "chr": "chr1",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "desflurane",
          "id": "RxNorm:27340"
        },
        {
          "name": "enflurane",
          "id": "RxNorm:3920"
        },
        {
          "name": "halothane",
          "id": "RxNorm:5095"
        },
        {
          "name": "isoflurane",
          "id": "RxNorm:6026"
        },
        {
          "name": "methoxyflurane",
          "id": "RxNorm:6857"
        },
        {
          "name": "sevoflurane",
          "id": "RxNorm:36453"
        },
        {
          "name": "succinylcholine",
          "id": "RxNorm:10154"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CACNA1S",
            "name": "Reference",
            "function": "Normal Function",
            "reference": true
          },
          "allele2": {
            "gene": "CACNA1S",
            "name": "Reference",
            "function": "Normal Function",
            "reference": true
          },
          "gene": "CACNA1S",
          "phenotypes": [
            "Uncertain Susceptibility"
          ],
          "variant": null,
          "lookupKey": [
            "Uncertain Susceptibility"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CACNA1S",
            "name": "Reference",
            "function": "Normal Function",
            "reference": true
          },
          "allele2": {
            "gene": "CACNA1S",
            "name": "Reference",
            "function": "Normal Function",
            "reference": true
          },
          "gene": "CACNA1S",
          "phenotypes": [
            "Uncertain Susceptibility"
          ],
          "variant": null,
          "lookupKey": [
            "Uncertain Susceptibility"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CACNA1S",
          "chromosome": "chr1",
          "position": 201060815,
          "dbSnpId": "rs1800559",
          "call": "C/C",
          "alleles": [
            "c.3257G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CACNA1S",
          "chromosome": "chr1",
          "position": 201091993,
          "dbSnpId": "rs772226819",
          "call": "G/G",
          "alleles": [
            "c.520C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CFTR",
      "chr": "chr7",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "ivacaftor",
          "id": "RxNorm:1243041"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CFTR",
            "name": "ivacaftor non-responsive CFTR sequence",
            "function": "ivacaftor non-responsive",
            "reference": true
          },
          "allele2": {
            "gene": "CFTR",
            "name": "ivacaftor non-responsive CFTR sequence",
            "function": "ivacaftor non-responsive",
            "reference": true
          },
          "gene": "CFTR",
          "phenotypes": [
            "ivacaftor non-responsive in CF patients"
          ],
          "variant": null,
          "lookupKey": [
            "ivacaftor non-responsive in CF patients"
          ],
          "label": "No CPIC variants found",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CFTR",
            "name": "ivacaftor non-responsive CFTR sequence",
            "function": "ivacaftor non-responsive",
            "reference": true
          },
          "allele2": {
            "gene": "CFTR",
            "name": "ivacaftor non-responsive CFTR sequence",
            "function": "ivacaftor non-responsive",
            "reference": true
          },
          "gene": "CFTR",
          "phenotypes": [
            "ivacaftor non-responsive in CF patients"
          ],
          "variant": null,
          "lookupKey": [
            "ivacaftor non-responsive in CF patients"
          ],
          "label": "No CPIC variants found",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509035,
          "dbSnpId": "rs397508256",
          "call": "G/G",
          "alleles": [
            "E56K"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509069,
          "dbSnpId": "rs368505753",
          "call": "C/C",
          "alleles": [
            "P67L"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117509089,
          "dbSnpId": "rs115545701",
          "call": "C/C",
          "alleles": [
            "R74W"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530953,
          "dbSnpId": "rs113993958",
          "call": "G/G",
          "alleles": [
            "D110H"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530955,
          "dbSnpId": "rs397508537",
          "call": "C/C",
          "alleles": [
            "D110E"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530974,
          "dbSnpId": "rs77834169",
          "call": "C/C",
          "alleles": [
            "R117C"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117530975,
          "dbSnpId": "rs78655421",
          "call": "G/G",
          "alleles": [
            "R117H"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534318,
          "dbSnpId": "rs80282562",
          "call": "G/G",
          "alleles": [
            "G178R"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534363,
          "dbSnpId": "rs397508759",
          "call": "G/G",
          "alleles": [
            "E193K"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117534368,
          "dbSnpId": "rs397508761",
          "call": "A/A",
          "alleles": [
            "711+3A-\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117535285,
          "dbSnpId": "rs121908752",
          "call": "T/T",
          "alleles": [
            "L206W"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117540270,
          "dbSnpId": "rs77932196",
          "call": "G/G",
          "alleles": [
            "R347H"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117540285,
          "dbSnpId": "rs121908753",
          "call": "G/G",
          "alleles": [
            "R352Q"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117548795,
          "dbSnpId": "rs74551128",
          "call": "C/C",
          "alleles": [
            "A455E"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587799,
          "dbSnpId": "rs121908757",
          "call": "A/A",
          "alleles": [
            "S549R(A\u003eC)"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587800,
          "dbSnpId": "rs121908755",
          "call": "G/G",
          "alleles": [
            "S549N"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587801,
          "dbSnpId": "rs121909005",
          "call": "T/T",
          "alleles": [
            "S549R(T\u003eG)"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587805,
          "dbSnpId": "rs121909013",
          "call": "G/G",
          "alleles": [
            "G551S"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117587806,
          "dbSnpId": "rs75527207",
          "call": "G/G",
          "alleles": [
            "G551D"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117590409,
          "dbSnpId": "rs397508288",
          "call": "A/A",
          "alleles": [
            "D579G"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117594930,
          "dbSnpId": "rs397508387",
          "call": "G/G",
          "alleles": [
            "E831X"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117602868,
          "dbSnpId": "rs80224560",
          "call": "G/G",
          "alleles": [
            "2789+5G-\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117603708,
          "dbSnpId": "rs397508442",
          "call": "C/C",
          "alleles": [
            "S945L"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117606695,
          "dbSnpId": "rs141033578",
          "call": "C/C",
          "alleles": [
            "S977F"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611555,
          "dbSnpId": "rs76151804",
          "call": "A/A",
          "alleles": [
            "3272-26A-\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611595,
          "dbSnpId": "rs150212784",
          "call": "T/T",
          "alleles": [
            "F1052V"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611620,
          "dbSnpId": "rs397508513",
          "call": "A/A",
          "alleles": [
            "K1060T"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611640,
          "dbSnpId": "rs121909020",
          "call": "G/G",
          "alleles": [
            "A1067T"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611646,
          "dbSnpId": "rs200321110",
          "call": "G/G",
          "alleles": [
            "G1069R"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611649,
          "dbSnpId": "rs202179988",
          "call": "C/C",
          "alleles": [
            "R1070W"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611650,
          "dbSnpId": "rs78769542",
          "call": "G/G",
          "alleles": [
            "R1070Q"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117611663,
          "dbSnpId": "rs186045772",
          "call": "T/T",
          "alleles": [
            "F1074L"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117614699,
          "dbSnpId": "rs75541969",
          "call": "G/G",
          "alleles": [
            "D1152H"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117639961,
          "dbSnpId": "rs75039782",
          "call": "C/C",
          "alleles": [
            "3849+10kbC-\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642451,
          "dbSnpId": "rs267606723",
          "call": "G/G",
          "alleles": [
            "G1244E"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642472,
          "dbSnpId": "rs74503330",
          "call": "G/G",
          "alleles": [
            "S1251N"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642483,
          "dbSnpId": "rs121909041",
          "call": "T/T",
          "alleles": [
            "S1255P"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117642528,
          "dbSnpId": "rs11971167",
          "call": "G/G",
          "alleles": [
            "D1270N"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CFTR",
          "chromosome": "chr7",
          "position": 117664770,
          "dbSnpId": "rs193922525",
          "call": "G/G",
          "alleles": [
            "G1349D"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP2B6",
      "chr": "chr19",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "efavirenz",
          "id": "RxNorm:195085"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP2B6",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2B6",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP2B6",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP2B6",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2B6",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP2B6",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991224,
          "dbSnpId": "rs34223104",
          "call": "T/T",
          "alleles": [
            "*22",
            "*34",
            "*35",
            "*36"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991367,
          "dbSnpId": "rs34883432",
          "call": "A/A",
          "alleles": [
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991369,
          "dbSnpId": "rs8192709",
          "call": "C/C",
          "alleles": [
            "*2",
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991381,
          "dbSnpId": "rs33973337",
          "call": "A/A",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991388,
          "dbSnpId": "rs33980385",
          "call": "A/A",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991390,
          "dbSnpId": "rs33926104",
          "call": "C/C",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991391,
          "dbSnpId": "rs34284776",
          "call": "G/G",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 40991441,
          "dbSnpId": "rs35303484",
          "call": "A/A",
          "alleles": [
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004015,
          "dbSnpId": "rs281864907",
          "call": "T/T",
          "alleles": [
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004125,
          "dbSnpId": "rs36060847",
          "call": "G/G",
          "alleles": [
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004158,
          "dbSnpId": "rs186335453",
          "call": "G/G",
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004303,
          "dbSnpId": "rs139801276",
          "call": "T/T",
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004377,
          "dbSnpId": "rs12721655",
          "call": "A/A",
          "alleles": [
            "*8",
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004381,
          "dbSnpId": "rs35773040",
          "call": "G/G",
          "alleles": [
            "*14"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41004406,
          "dbSnpId": "rs145884402",
          "call": "G/G",
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006919,
          "dbSnpId": "rs3826711",
          "call": "C/C",
          "alleles": [
            "*26"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006923,
          "dbSnpId": "rs36056539",
          "call": "C/C",
          "alleles": [
            "*20"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006936,
          "dbSnpId": "rs3745274",
          "call": "G/G",
          "alleles": [
            "*6",
            "*7",
            "*9",
            "*13",
            "*19",
            "*20",
            "*26",
            "*34",
            "*36",
            "*37",
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41006968,
          "dbSnpId": "rs373489637",
          "call": "T/T",
          "alleles": [
            "*37"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41007013,
          "dbSnpId": "rs36079186",
          "call": "T/T",
          "alleles": [
            "*27",
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41009350,
          "dbSnpId": "rs45482602",
          "call": "C/C",
          "alleles": [
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41009358,
          "dbSnpId": "rs2279343",
          "call": "A/A",
          "alleles": [
            "*4",
            "*6",
            "*7",
            "*13",
            "*18",
            "*19",
            "*20",
            "*26",
            "*34",
            "*36",
            "*37",
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010006,
          "dbSnpId": "rs139029625",
          "call": "G/G",
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010088,
          "dbSnpId": "rs34698757",
          "call": "C/C",
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41010108,
          "dbSnpId": "rs193922917",
          "call": "C/C",
          "alleles": [
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012316,
          "dbSnpId": "rs28399499",
          "call": "T/T",
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012339,
          "dbSnpId": "rs34826503",
          "call": "C/C",
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012465,
          "dbSnpId": "rs34097093",
          "call": "C/C",
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012693,
          "dbSnpId": "rs35979566",
          "call": "T/T",
          "alleles": [
            "*15"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012740,
          "dbSnpId": "rs193922918",
          "call": "G/G",
          "alleles": [
            "*32"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41012803,
          "dbSnpId": "rs35010098",
          "call": "C/C",
          "alleles": [
            "*21"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016726,
          "dbSnpId": "rs3211369",
          "call": "A/A",
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016778,
          "dbSnpId": "rs564083989",
          "call": "G/G",
          "alleles": [
            "*24"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016805,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*25"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2B6",
          "chromosome": "chr19",
          "position": 41016810,
          "dbSnpId": "rs3211371",
          "call": "C/C",
          "alleles": [
            "*5",
            "*7",
            "*33",
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP2C19",
      "chr": "chr10",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "amitriptyline",
          "id": "RxNorm:704"
        },
        {
          "name": "citalopram",
          "id": "RxNorm:2556"
        },
        {
          "name": "clomipramine",
          "id": "RxNorm:2597"
        },
        {
          "name": "clopidogrel",
          "id": "RxNorm:32968"
        },
        {
          "name": "dexlansoprazole",
          "id": "RxNorm:816346"
        },
        {
          "name": "doxepin",
          "id": "RxNorm:3638"
        },
        {
          "name": "escitalopram",
          "id": "RxNorm:321988"
        },
        {
          "name": "imipramine",
          "id": "RxNorm:5691"
        },
        {
          "name": "lansoprazole",
          "id": "RxNorm:17128"
        },
        {
          "name": "omeprazole",
          "id": "RxNorm:7646"
        },
        {
          "name": "pantoprazole",
          "id": "RxNorm:40790"
        },
        {
          "name": "sertraline",
          "id": "RxNorm:36437"
        },
        {
          "name": "trimipramine",
          "id": "RxNorm:10834"
        },
        {
          "name": "voriconazole",
          "id": "RxNorm:121243"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP2C19",
            "name": "*38",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2C19",
            "name": "*38",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP2C19",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*38/*38",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP2C19",
            "name": "*38",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2C19",
            "name": "*38",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP2C19",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*38/*38",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94761900,
          "dbSnpId": "rs12248560",
          "call": "C/C",
          "alleles": [
            "*4",
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762706,
          "dbSnpId": "rs28399504",
          "call": "A/A",
          "alleles": [
            "*4"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762712,
          "dbSnpId": "rs367543002",
          "call": "C/C",
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762715,
          "dbSnpId": "rs367543003",
          "call": "T/T",
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762755,
          "dbSnpId": "rs55752064",
          "call": "T/T",
          "alleles": [
            "*14"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762760,
          "dbSnpId": "rs17882687",
          "call": "A/A",
          "alleles": [
            "*15",
            "*28",
            "*35",
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762788,
          "dbSnpId": "rs1564656981",
          "call": "A/A",
          "alleles": [
            "*29"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94762856,
          "dbSnpId": "rs1564657013",
          "call": "A/A",
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775106,
          "dbSnpId": "rs145328984",
          "call": "C/C",
          "alleles": [
            "*30"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775121,
          "dbSnpId": "rs1564660997",
          "call": "C/C",
          "alleles": [
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775160,
          "dbSnpId": "rs118203756",
          "call": "G/G",
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775185,
          "dbSnpId": "rs1288601658",
          "call": "A/A",
          "alleles": [
            "*32"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775367,
          "dbSnpId": "rs12769205",
          "call": "A/A",
          "alleles": [
            "*2",
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775416,
          "dbSnpId": "rs41291556",
          "call": "T/T",
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775423,
          "dbSnpId": "rs17885179",
          "call": "A/A",
          "alleles": [
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775453,
          "dbSnpId": "rs72552267",
          "call": "G/G",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775489,
          "dbSnpId": "rs17884712",
          "call": "G/G",
          "alleles": [
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94775507,
          "dbSnpId": "rs58973490",
          "call": "G/G",
          "alleles": [
            "*2",
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780574,
          "dbSnpId": "rs140278421",
          "call": "G/G",
          "alleles": [
            "*22"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780579,
          "dbSnpId": "rs370803989",
          "call": "G/G",
          "alleles": [
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94780653,
          "dbSnpId": "rs4986893",
          "call": "G/G",
          "alleles": [
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781858,
          "dbSnpId": "rs6413438",
          "call": "C/C",
          "alleles": [
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781859,
          "dbSnpId": "rs4244285",
          "call": "G/G",
          "alleles": [
            "*2"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781944,
          "dbSnpId": "rs375781227",
          "call": "G/G",
          "alleles": [
            "*26"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94781999,
          "dbSnpId": "rs72558186",
          "call": "T/T",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842861,
          "dbSnpId": "rs138142612",
          "call": "G/G",
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842866,
          "dbSnpId": "rs3758581",
          "call": "A/A",
          "alleles": [
            "*2",
            "*3",
            "*4",
            "*5",
            "*6",
            "*8",
            "*9",
            "*10",
            "*11",
            "*12",
            "*13",
            "*14",
            "*15",
            "*17",
            "*18",
            "*19",
            "*22",
            "*23",
            "*24",
            "*25",
            "*26",
            "*28",
            "*29",
            "*31",
            "*32",
            "*33",
            "*35",
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842879,
          "dbSnpId": "rs118203757",
          "call": "G/G",
          "alleles": [
            "*24"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94842995,
          "dbSnpId": "rs113934938",
          "call": "G/G",
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94849995,
          "dbSnpId": "rs17879685",
          "call": "C/C",
          "alleles": [
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852738,
          "dbSnpId": "rs56337013",
          "call": "C/C",
          "alleles": [
            "*5"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852765,
          "dbSnpId": "rs192154563",
          "call": "C/C",
          "alleles": [
            "*16"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852785,
          "dbSnpId": "rs118203759",
          "call": "C/C",
          "alleles": [
            "*25"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C19",
          "chromosome": "chr10",
          "position": 94852914,
          "dbSnpId": "rs55640102",
          "call": "A/A",
          "alleles": [
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP2C9",
      "chr": "chr10",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [
        "*72",
        "*73",
        "*74",
        "*75",
        "*76",
        "*77",
        "*78",
        "*79",
        "*80",
        "*81",
        "*82",
        "*83",
        "*84",
        "*85"
      ],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "celecoxib",
          "id": "RxNorm:140587"
        },
        {
          "name": "flurbiprofen",
          "id": "RxNorm:4502"
        },
        {
          "name": "fluvastatin",
          "id": "RxNorm:41127"
        },
        {
          "name": "fosphenytoin",
          "id": "RxNorm:72236"
        },
        {
          "name": "ibuprofen",
          "id": "RxNorm:5640"
        },
        {
          "name": "lornoxicam",
          "id": "RxNorm:20890"
        },
        {
          "name": "meloxicam",
          "id": "RxNorm:41493"
        },
        {
          "name": "phenytoin",
          "id": "RxNorm:8183"
        },
        {
          "name": "piroxicam",
          "id": "RxNorm:8356"
        },
        {
          "name": "siponimod",
          "id": "PA166211021"
        },
        {
          "name": "tenoxicam",
          "id": "RxNorm:37790"
        },
        {
          "name": "warfarin",
          "id": "RxNorm:11289"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP2C9",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2C9",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP2C9",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "2"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP2C9",
            "name": "*1",
            "function": "Normal function (CYP2C9*1)",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2C9",
            "name": "*1",
            "function": "Normal function (CYP2C9*1)",
            "reference": true
          },
          "gene": "CYP2C9",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "2"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938683,
          "dbSnpId": "rs114071557",
          "call": "A/A",
          "alleles": [
            "*36"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938737,
          "dbSnpId": "rs67807361",
          "call": "C/C",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938771,
          "dbSnpId": "rs142240658",
          "call": "C/C",
          "alleles": [
            "*21"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938803,
          "dbSnpId": "rs2031308986",
          "call": "A/A",
          "alleles": [
            "*22"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938828,
          "dbSnpId": "rs564813580",
          "call": "A/A",
          "alleles": [
            "*37"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941897,
          "dbSnpId": "rs371055887",
          "call": "G/G",
          "alleles": [
            "*20"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941915,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941958,
          "dbSnpId": "rs72558187",
          "call": "T/T",
          "alleles": [
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941976,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941982,
          "dbSnpId": "rs762239445",
          "call": "G/G",
          "alleles": [
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942018,
          "dbSnpId": null,
          "call": "T/T",
          "alleles": [
            "*40"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942205,
          "dbSnpId": "rs1304490498",
          "call": "CAATGGAAAGA/CAATGGAAAGA",
          "alleles": [
            "*25"
          ],
          "phased": false,
          "wildtypeAllele": "CAATGGAAAGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942216,
          "dbSnpId": "rs774607211",
          "call": "A/A",
          "alleles": [
            "*41"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942230,
          "dbSnpId": "rs767576260",
          "call": "C/C",
          "alleles": [
            "*43"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942231,
          "dbSnpId": "rs12414460",
          "call": "G/G",
          "alleles": [
            "*42"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942233,
          "dbSnpId": "rs375805362",
          "call": "C/C",
          "alleles": [
            "*62"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942234,
          "dbSnpId": "rs72558189",
          "call": "G/G",
          "alleles": [
            "*14",
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942249,
          "dbSnpId": "rs200965026",
          "call": "C/C",
          "alleles": [
            "*26",
            "*44"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942254,
          "dbSnpId": "rs199523631",
          "call": "C/C",
          "alleles": [
            "*45"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942255,
          "dbSnpId": "rs200183364",
          "call": "G/G",
          "alleles": [
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942290,
          "dbSnpId": "rs1799853",
          "call": "C/C",
          "alleles": [
            "*2",
            "*35",
            "*61"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942291,
          "dbSnpId": "rs141489852",
          "call": "G/G",
          "alleles": [
            "*63"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942305,
          "dbSnpId": "rs754487195",
          "call": "G/G",
          "alleles": [
            "*46"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942309,
          "dbSnpId": "rs7900194",
          "call": "G/G",
          "alleles": [
            "*8",
            "*27"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947782,
          "dbSnpId": "rs72558190",
          "call": "C/C",
          "alleles": [
            "*15"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947785,
          "dbSnpId": "rs774550549",
          "call": "C/C",
          "alleles": [
            "*47"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947869,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*69"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947907,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*57"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947917,
          "dbSnpId": "rs1326630788",
          "call": "T/T",
          "alleles": [
            "*48"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947938,
          "dbSnpId": "rs2031531005",
          "call": "A/A",
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949129,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*49"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949144,
          "dbSnpId": null,
          "call": "C/C",
          "alleles": [
            "*50"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949217,
          "dbSnpId": "rs2256871",
          "call": "A/A",
          "alleles": [
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949280,
          "dbSnpId": "rs9332130",
          "call": "A/A",
          "alleles": [
            "*10",
            "*71"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949281,
          "dbSnpId": "rs9332131",
          "call": "GA/GA",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "GA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972119,
          "dbSnpId": "rs182132442",
          "call": "C/C",
          "alleles": [
            "*29"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972123,
          "dbSnpId": null,
          "call": "C/C",
          "alleles": [
            "*64"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972134,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*51"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972179,
          "dbSnpId": "rs72558192",
          "call": "A/A",
          "alleles": [
            "*16"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972180,
          "dbSnpId": "rs988617574",
          "call": "C/C",
          "alleles": [
            "*52"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972233,
          "dbSnpId": "rs1237225311",
          "call": "C/C",
          "alleles": [
            "*53"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981199,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*65"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981201,
          "dbSnpId": "rs57505750",
          "call": "T/T",
          "alleles": [
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981224,
          "dbSnpId": "rs28371685",
          "call": "C/C",
          "alleles": [
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981225,
          "dbSnpId": "rs367826293",
          "call": "G/G",
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981230,
          "dbSnpId": "rs1274535931",
          "call": "C/C",
          "alleles": [
            "*58"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981250,
          "dbSnpId": "rs750820937",
          "call": "C/C",
          "alleles": [
            "*54"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981281,
          "dbSnpId": "rs749060448",
          "call": "G/G",
          "alleles": [
            "*24"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981296,
          "dbSnpId": "rs1057910",
          "call": "A/A",
          "alleles": [
            "*3",
            "*18",
            "*68"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981297,
          "dbSnpId": "rs56165452",
          "call": "T/T",
          "alleles": [
            "*4"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981301,
          "dbSnpId": "rs28371686",
          "call": "C/C",
          "alleles": [
            "*5"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981302,
          "dbSnpId": "rs1250577724",
          "call": "C/C",
          "alleles": [
            "*55"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981305,
          "dbSnpId": "rs578144976",
          "call": "C/C",
          "alleles": [
            "*66"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981365,
          "dbSnpId": null,
          "call": "C/C",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981371,
          "dbSnpId": "rs542577750",
          "call": "G/G",
          "alleles": [
            "*68"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986042,
          "dbSnpId": "rs764211126",
          "call": "A/A",
          "alleles": [
            "*56"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986073,
          "dbSnpId": "rs72558193",
          "call": "A/A",
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988852,
          "dbSnpId": "rs776908257",
          "call": "C/C",
          "alleles": [
            "*67"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988855,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*59"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988880,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*70"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988917,
          "dbSnpId": "rs769942899",
          "call": "G/G",
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988925,
          "dbSnpId": "rs202201137",
          "call": "A/A",
          "alleles": [
            "*61"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988955,
          "dbSnpId": "rs767284820",
          "call": "T/T",
          "alleles": [
            "*60"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94988984,
          "dbSnpId": "rs781583846",
          "call": "G/G",
          "alleles": [
            "*30"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94989020,
          "dbSnpId": "rs9332239",
          "call": "C/C",
          "alleles": [
            "*12",
            "*71"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94989023,
          "dbSnpId": "rs868182778",
          "call": "G/G",
          "alleles": [
            "*32"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938719,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*80"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938788,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*83"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94938800,
          "dbSnpId": "rs1364419386",
          "call": null,
          "alleles": [
            "*76"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94941975,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*77"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942243,
          "dbSnpId": "rs1375956433",
          "call": null,
          "alleles": [
            "*78"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942306,
          "dbSnpId": "rs1289704600",
          "call": null,
          "alleles": [
            "*72"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94942308,
          "dbSnpId": "rs17847037",
          "call": null,
          "alleles": [
            "*73"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94947939,
          "dbSnpId": "rs370100007",
          "call": null,
          "alleles": [
            "*74"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949145,
          "dbSnpId": "rs772782449",
          "call": null,
          "alleles": [
            "*82"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94949161,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*85"
          ],
          "phased": false,
          "wildtypeAllele": "AT",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94972183,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*81"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94981258,
          "dbSnpId": "rs1297714792",
          "call": null,
          "alleles": [
            "*79"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986136,
          "dbSnpId": "rs1254213342",
          "call": null,
          "alleles": [
            "*75"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94986174,
          "dbSnpId": "rs1441296358",
          "call": null,
          "alleles": [
            "*84"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [
        {
          "gene": "CYP2C9",
          "chromosome": "chr10",
          "position": 94645745,
          "dbSnpId": "rs12777823",
          "call": "G/G",
          "alleles": [],
          "phased": false,
          "wildtypeAllele": null,
          "mismatch": false,
          "warnings": []
        }
      ],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP2D6",
      "chr": null,
      "phased": false,
      "callSource": "OUTSIDE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "amitriptyline",
          "id": "RxNorm:704"
        },
        {
          "name": "aripiprazole",
          "id": "PA166104937"
        },
        {
          "name": "atomoxetine",
          "id": "RxNorm:38400"
        },
        {
          "name": "brexpiprazole",
          "id": "PA166184527"
        },
        {
          "name": "clomipramine",
          "id": "RxNorm:2597"
        },
        {
          "name": "codeine",
          "id": "RxNorm:2670"
        },
        {
          "name": "desipramine",
          "id": "RxNorm:3247"
        },
        {
          "name": "doxepin",
          "id": "RxNorm:3638"
        },
        {
          "name": "eliglustat",
          "id": "PA166182823"
        },
        {
          "name": "flecainide",
          "id": "PA166104969"
        },
        {
          "name": "fluvoxamine",
          "id": "RxNorm:42355"
        },
        {
          "name": "haloperidol",
          "id": "PA166104988"
        },
        {
          "name": "hydrocodone",
          "id": "RxNorm:5489"
        },
        {
          "name": "imipramine",
          "id": "RxNorm:5691"
        },
        {
          "name": "metoprolol",
          "id": "PA166104995"
        },
        {
          "name": "nortriptyline",
          "id": "RxNorm:7531"
        },
        {
          "name": "ondansetron",
          "id": "RxNorm:26225"
        },
        {
          "name": "paroxetine",
          "id": "RxNorm:32937"
        },
        {
          "name": "pimozide",
          "id": "PA166182819"
        },
        {
          "name": "propafenone",
          "id": "PA166104962"
        },
        {
          "name": "risperidone",
          "id": "PA166104943"
        },
        {
          "name": "tamoxifen",
          "id": "RxNorm:10324"
        },
        {
          "name": "tramadol",
          "id": "RxNorm:10689"
        },
        {
          "name": "trimipramine",
          "id": "RxNorm:10834"
        },
        {
          "name": "tropisetron",
          "id": "RxNorm:27392"
        },
        {
          "name": "venlafaxine",
          "id": "PA166104968"
        },
        {
          "name": "zuclopenthixol",
          "id": "PA166104992"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP2D6",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP2D6",
            "name": "*3",
            "function": "No function",
            "reference": false
          },
          "gene": "CYP2D6",
          "phenotypes": [
            "Intermediate Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "1"
          ],
          "label": "*1/*3",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP3A4",
      "chr": "chr7",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [
        "*1",
        "*10",
        "*11",
        "*12",
        "*13",
        "*14",
        "*15",
        "*16",
        "*17",
        "*18",
        "*19",
        "*2",
        "*20",
        "*21",
        "*22",
        "*23",
        "*24",
        "*26",
        "*28",
        "*29",
        "*3",
        "*30",
        "*31",
        "*32",
        "*33",
        "*34",
        "*35",
        "*36",
        "*4",
        "*5",
        "*6",
        "*7",
        "*8",
        "*9"
      ],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "quetiapine",
          "id": "PA166265421"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP3A4",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "allele2": {
            "gene": "CYP3A4",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "gene": "CYP3A4",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP3A4",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "allele2": {
            "gene": "CYP3A4",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "gene": "CYP3A4",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99758183,
          "dbSnpId": "rs67666821",
          "call": null,
          "alleles": [
            "*20"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99760836,
          "dbSnpId": "rs4986913",
          "call": null,
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99760901,
          "dbSnpId": "rs4986910",
          "call": null,
          "alleles": [
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99760956,
          "dbSnpId": "rs774109750",
          "call": null,
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99762047,
          "dbSnpId": "rs4986909",
          "call": null,
          "alleles": [
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99762177,
          "dbSnpId": "rs12721629",
          "call": null,
          "alleles": [
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99762186,
          "dbSnpId": "rs756833413",
          "call": null,
          "alleles": [
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99762206,
          "dbSnpId": "rs67784355",
          "call": null,
          "alleles": [
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99763843,
          "dbSnpId": "rs2242480",
          "call": null,
          "alleles": [
            "*8",
            "*9",
            "*12",
            "*15",
            "*16",
            "*18",
            "*19",
            "*23",
            "*24",
            "*28",
            "*36"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99763877,
          "dbSnpId": "rs368296206",
          "call": null,
          "alleles": [
            "*32"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99763909,
          "dbSnpId": "rs1303250043",
          "call": null,
          "alleles": [
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99763925,
          "dbSnpId": "rs201821708",
          "call": null,
          "alleles": [
            "*21"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99764003,
          "dbSnpId": "rs28371759",
          "call": null,
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99766411,
          "dbSnpId": "rs4646438",
          "call": null,
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99766440,
          "dbSnpId": "rs138105638",
          "call": null,
          "alleles": [
            "*26"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768360,
          "dbSnpId": "rs55785340",
          "call": null,
          "alleles": [
            "*2"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768371,
          "dbSnpId": "rs55901263",
          "call": null,
          "alleles": [
            "*5"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768424,
          "dbSnpId": "rs113667357",
          "call": null,
          "alleles": [
            "*24"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768458,
          "dbSnpId": "rs4987161",
          "call": null,
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768470,
          "dbSnpId": "rs12721627",
          "call": null,
          "alleles": [
            "*16"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99768693,
          "dbSnpId": "rs35599367",
          "call": null,
          "alleles": [
            "*22"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99769769,
          "dbSnpId": "rs4986908",
          "call": null,
          "alleles": [
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99769781,
          "dbSnpId": "rs72552798",
          "call": null,
          "alleles": [
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99769804,
          "dbSnpId": "rs4986907",
          "call": null,
          "alleles": [
            "*15"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99769805,
          "dbSnpId": "rs57409622",
          "call": null,
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99770165,
          "dbSnpId": "rs72552799",
          "call": null,
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99770166,
          "dbSnpId": "rs778013004",
          "call": null,
          "alleles": [
            "*30"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99770202,
          "dbSnpId": "rs55951658",
          "call": null,
          "alleles": [
            "*4"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99770217,
          "dbSnpId": "rs1449865051",
          "call": null,
          "alleles": [
            "*29"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99778079,
          "dbSnpId": "rs56324128",
          "call": null,
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99784018,
          "dbSnpId": "rs570051168",
          "call": null,
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99784038,
          "dbSnpId": "rs12721634",
          "call": null,
          "alleles": [
            "*14"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A4",
          "chromosome": "chr7",
          "position": 99784075,
          "dbSnpId": "rs188389063",
          "call": null,
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP3A5",
      "chr": "chr7",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "CYP3A5 reverse complement footnote",
          "version": "1",
          "matches": {
            "gene": "CYP3A5",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "The CYP3A5 gene is on the negative chromosomal strand, all genotype calls for CYP3A5 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
        }
      ],
      "relatedDrugs": [
        {
          "name": "tacrolimus",
          "id": "RxNorm:42316"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP3A5",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP3A5",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP3A5",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP3A5",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "CYP3A5",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "CYP3A5",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99652770,
          "dbSnpId": "rs41303343",
          "call": "T/T",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99660516,
          "dbSnpId": "rs28383479",
          "call": "C/C",
          "alleles": [
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99665212,
          "dbSnpId": "rs10264272",
          "call": "C/C",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99672916,
          "dbSnpId": "rs776746",
          "call": "T/T",
          "alleles": [
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP3A5",
          "chromosome": "chr7",
          "position": 99676198,
          "dbSnpId": "rs55817950",
          "call": "G/G",
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "CYP4F2",
      "chr": "chr19",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "warfarin",
          "id": "RxNorm:11289"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "CYP4F2",
            "name": "*1",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "CYP4F2",
            "name": "*1",
            "function": null,
            "reference": true
          },
          "gene": "CYP4F2",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "CYP4F2",
            "name": "*1",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "CYP4F2",
            "name": "*1",
            "function": null,
            "reference": true
          },
          "gene": "CYP4F2",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "CYP4F2",
          "chromosome": "chr19",
          "position": 15879621,
          "dbSnpId": "rs2108622",
          "call": "C/C",
          "alleles": [
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "CYP4F2",
          "chromosome": "chr19",
          "position": 15897578,
          "dbSnpId": "rs3093105",
          "call": "A/A",
          "alleles": [
            "*2"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "DPYD",
      "chr": "chr1",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "DPYD reverse complement footnote",
          "version": "1",
          "matches": {
            "gene": "DPYD",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "The DPYD gene is on the negative chromosomal strand, all genotype calls for DPYD in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
        }
      ],
      "relatedDrugs": [
        {
          "name": "capecitabine",
          "id": "RxNorm:194000"
        },
        {
          "name": "flucytosine",
          "id": "PA166222801"
        },
        {
          "name": "fluorouracil",
          "id": "RxNorm:4492"
        },
        {
          "name": "tegafur",
          "id": "PA166104944"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "DPYD",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "DPYD",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "gene": "DPYD",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "2"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "DPYD",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "DPYD",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "gene": "DPYD",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "2"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97078987,
          "dbSnpId": "rs114096998",
          "call": "G/G",
          "alleles": [
            "c.3067C\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97078993,
          "dbSnpId": "rs148799944",
          "call": "C/C",
          "alleles": [
            "c.3061G\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079005,
          "dbSnpId": "rs140114515",
          "call": "C/C",
          "alleles": [
            "c.3049G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079071,
          "dbSnpId": "rs1801268",
          "call": "C/C",
          "alleles": [
            "c.2983G\u003eT (*10)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079076,
          "dbSnpId": "rs139459586",
          "call": "A/A",
          "alleles": [
            "c.2978T\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079077,
          "dbSnpId": "rs202144771",
          "call": "G/G",
          "alleles": [
            "c.2977C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079121,
          "dbSnpId": "rs72547601",
          "call": "T/T",
          "alleles": [
            "c.2933A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079133,
          "dbSnpId": "rs72547602",
          "call": "T/T",
          "alleles": [
            "c.2921A\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97079139,
          "dbSnpId": "rs145529148",
          "call": "T/T",
          "alleles": [
            "c.2915A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97082365,
          "dbSnpId": "rs141044036",
          "call": "T/T",
          "alleles": [
            "c.2872A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97082391,
          "dbSnpId": "rs67376798",
          "call": "T/T",
          "alleles": [
            "c.2846A\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098598,
          "dbSnpId": "rs1801267",
          "call": "C/C",
          "alleles": [
            "c.2657G\u003eA (*9B)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098599,
          "dbSnpId": "rs147545709",
          "call": "G/G",
          "alleles": [
            "c.2656C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098616,
          "dbSnpId": "rs55674432",
          "call": "C/C",
          "alleles": [
            "c.2639G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97098632,
          "dbSnpId": "rs201035051",
          "call": "T/T",
          "alleles": [
            "c.2623A\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97193109,
          "dbSnpId": "rs60139309",
          "call": "T/T",
          "alleles": [
            "c.2582A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97193209,
          "dbSnpId": "rs200687447",
          "call": "C/C",
          "alleles": [
            "c.2482G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97234958,
          "dbSnpId": "rs199634007",
          "call": "G/G",
          "alleles": [
            "c.2336C\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97234991,
          "dbSnpId": "rs56005131",
          "call": "G/G",
          "alleles": [
            "c.2303C\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305279,
          "dbSnpId": "rs112766203",
          "call": "G/G",
          "alleles": [
            "c.2279C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305363,
          "dbSnpId": "rs60511679",
          "call": "A/A",
          "alleles": [
            "c.2195T\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305364,
          "dbSnpId": "rs1801160",
          "call": "C/C",
          "alleles": [
            "c.2194G\u003eA (*6)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97305372,
          "dbSnpId": "rs146529561",
          "call": "G/G",
          "alleles": [
            "c.2186C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97306195,
          "dbSnpId": "rs145548112",
          "call": "C/C",
          "alleles": [
            "c.2161G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97373598,
          "dbSnpId": "rs137999090",
          "call": "C/C",
          "alleles": [
            "c.2021G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97373629,
          "dbSnpId": "rs138545885",
          "call": "C/C",
          "alleles": [
            "c.1990G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97382461,
          "dbSnpId": "rs55971861",
          "call": "T/T",
          "alleles": [
            "c.1906A\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450058,
          "dbSnpId": "rs3918290",
          "call": "C/C",
          "alleles": [
            "c.1905+1G\u003eA (*2A)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450059,
          "dbSnpId": "rs3918289",
          "call": "G/G",
          "alleles": [
            "c.1905C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450065,
          "dbSnpId": "rs72549303",
          "call": "TG/TG",
          "alleles": [
            "c.1898delC (*3)"
          ],
          "phased": false,
          "wildtypeAllele": "TG",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450068,
          "dbSnpId": "rs17376848",
          "call": "A/A",
          "alleles": [
            "c.1896T\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450168,
          "dbSnpId": "rs147601618",
          "call": "A/A",
          "alleles": [
            "c.1796T\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450187,
          "dbSnpId": "rs145773863",
          "call": "C/C",
          "alleles": [
            "c.1777G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450189,
          "dbSnpId": "rs138616379",
          "call": "C/C",
          "alleles": [
            "c.1775G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97450190,
          "dbSnpId": "rs59086055",
          "call": "G/G",
          "alleles": [
            "c.1774C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515784,
          "dbSnpId": "rs201615754",
          "call": "C/C",
          "alleles": [
            "c.1682G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515787,
          "dbSnpId": "rs55886062",
          "call": "A/A",
          "alleles": [
            "c.1679T\u003eG (*13)"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515839,
          "dbSnpId": "rs1801159",
          "call": "T/T",
          "alleles": [
            "c.1627A\u003eG (*5)"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515851,
          "dbSnpId": "rs142619737",
          "call": "C/C",
          "alleles": [
            "c.1615G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515865,
          "dbSnpId": "rs1801158",
          "call": "C/C",
          "alleles": [
            "c.1601G\u003eA (*4)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515889,
          "dbSnpId": "rs190951787",
          "call": "G/G",
          "alleles": [
            "c.1577C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97515923,
          "dbSnpId": "rs148994843",
          "call": "C/C",
          "alleles": [
            "c.1543G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549565,
          "dbSnpId": "rs138391898",
          "call": "C/C",
          "alleles": [
            "c.1519G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549600,
          "dbSnpId": "rs111858276",
          "call": "T/T",
          "alleles": [
            "c.1484A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549609,
          "dbSnpId": "rs72549304",
          "call": "G/G",
          "alleles": [
            "c.1475C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549681,
          "dbSnpId": "rs199549923",
          "call": "G/G",
          "alleles": [
            "c.1403C\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549713,
          "dbSnpId": "rs57918000",
          "call": "G/G",
          "alleles": [
            "c.1371C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549726,
          "dbSnpId": "rs144395748",
          "call": "G/G",
          "alleles": [
            "c.1358C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97549735,
          "dbSnpId": "rs72975710",
          "call": "G/G",
          "alleles": [
            "c.1349C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573785,
          "dbSnpId": "rs186169810",
          "call": "A/A",
          "alleles": [
            "c.1314T\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573805,
          "dbSnpId": "rs142512579",
          "call": "C/C",
          "alleles": [
            "c.1294G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573821,
          "dbSnpId": "rs764666241",
          "call": "C/C",
          "alleles": [
            "c.1278G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573839,
          "dbSnpId": "rs200064537",
          "call": "A/A",
          "alleles": [
            "c.1260T\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573863,
          "dbSnpId": "rs56038477",
          "call": "C/C",
          "alleles": [
            "c.1129-5923C\u003eG, c.1236G\u003eA (HapB3)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573881,
          "dbSnpId": "rs61622928",
          "call": "C/C",
          "alleles": [
            "c.1218G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573918,
          "dbSnpId": "rs143815742",
          "call": "C/C",
          "alleles": [
            "c.1181G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573919,
          "dbSnpId": "rs140602333",
          "call": "G/G",
          "alleles": [
            "c.1180C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97573943,
          "dbSnpId": "rs78060119",
          "call": "C/C",
          "alleles": [
            "c.1156G\u003eT (*12)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97579893,
          "dbSnpId": "rs75017182",
          "call": "G/G",
          "alleles": [
            "c.1129-5923C\u003eG, c.1236G\u003eA (HapB3)"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593238,
          "dbSnpId": "rs72549305",
          "call": "T/T",
          "alleles": [
            "c.1108A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593289,
          "dbSnpId": "rs143154602",
          "call": "G/G",
          "alleles": [
            "c.1057C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593322,
          "dbSnpId": "rs183385770",
          "call": "C/C",
          "alleles": [
            "c.1024G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593343,
          "dbSnpId": "rs72549306",
          "call": "C/C",
          "alleles": [
            "c.1003G\u003eT (*11)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97593379,
          "dbSnpId": "rs201018345",
          "call": "C/C",
          "alleles": [
            "c.967G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595083,
          "dbSnpId": "rs145112791",
          "call": "G/G",
          "alleles": [
            "c.934C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595088,
          "dbSnpId": "rs150437414",
          "call": "A/A",
          "alleles": [
            "c.929T\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97595149,
          "dbSnpId": "rs146356975",
          "call": "T/T",
          "alleles": [
            "c.868A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97679170,
          "dbSnpId": "rs45589337",
          "call": "T/T",
          "alleles": [
            "c.775A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97691776,
          "dbSnpId": "rs1801266",
          "call": "G/G",
          "alleles": [
            "c.703C\u003eT (*8)"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699399,
          "dbSnpId": "rs72549307",
          "call": "T/T",
          "alleles": [
            "c.632A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699430,
          "dbSnpId": "rs72549308",
          "call": "T/T",
          "alleles": [
            "c.601A\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699474,
          "dbSnpId": "rs115232898",
          "call": "T/T",
          "alleles": [
            "c.557A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699506,
          "dbSnpId": "rs6670886",
          "call": "C/C",
          "alleles": [
            "c.525G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699533,
          "dbSnpId": "rs139834141",
          "call": "C/C",
          "alleles": [
            "c.498G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97699535,
          "dbSnpId": "rs2297595",
          "call": "T/T",
          "alleles": [
            "c.496A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97721542,
          "dbSnpId": "rs200562975",
          "call": "T/T",
          "alleles": [
            "c.451A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97721650,
          "dbSnpId": "rs141462178",
          "call": "T/T",
          "alleles": [
            "c.343A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97740400,
          "dbSnpId": "rs150385342",
          "call": "C/C",
          "alleles": [
            "c.313G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97740410,
          "dbSnpId": "rs72549309",
          "call": "GATGA/GATGA",
          "alleles": [
            "c.295_298delTCAT (*7)"
          ],
          "phased": false,
          "wildtypeAllele": "GATGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883329,
          "dbSnpId": "rs1801265",
          "call": "A/A",
          "alleles": [
            "c.85T\u003eC (*9A)"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883352,
          "dbSnpId": "rs80081766",
          "call": "C/C",
          "alleles": [
            "c.62G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883353,
          "dbSnpId": "rs72549310",
          "call": "G/G",
          "alleles": [
            "c.61C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "DPYD",
          "chromosome": "chr1",
          "position": 97883368,
          "dbSnpId": "rs150036960",
          "call": "G/G",
          "alleles": [
            "c.46C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "F5",
      "chr": null,
      "phased": false,
      "callSource": "NONE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "hormonal contraceptives for systemic use",
          "id": "PA166104955"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "F5",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "allele2": {
            "gene": "F5",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "gene": "F5",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "G6PD",
      "chr": null,
      "phased": false,
      "callSource": "OUTSIDE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "rasburicase",
          "id": "RxNorm:283821"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "G6PD",
            "name": "B (wildtype)",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "G6PD",
            "name": "B (wildtype)",
            "function": "Normal function",
            "reference": true
          },
          "gene": "G6PD",
          "phenotypes": [
            "Normal"
          ],
          "variant": null,
          "lookupKey": [
            "Normal"
          ],
          "label": "B (wildtype)/B (wildtype)",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "HLA-A",
      "chr": null,
      "phased": false,
      "callSource": "NONE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "carbamazepine",
          "id": "RxNorm:2002"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "HLA-A",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "allele2": {
            "gene": "HLA-A",
            "name": "Unknown",
            "function": null,
            "reference": false
          },
          "gene": "HLA-A",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "Unknown/Unknown",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "HLA-B",
      "chr": null,
      "phased": false,
      "callSource": "OUTSIDE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "abacavir",
          "id": "RxNorm:190521"
        },
        {
          "name": "allopurinol",
          "id": "RxNorm:519"
        },
        {
          "name": "carbamazepine",
          "id": "RxNorm:2002"
        },
        {
          "name": "flucloxacillin",
          "id": "PA166182810"
        },
        {
          "name": "fosphenytoin",
          "id": "RxNorm:72236"
        },
        {
          "name": "lamotrigine",
          "id": "PA166265341"
        },
        {
          "name": "oxcarbazepine",
          "id": "RxNorm:32624"
        },
        {
          "name": "phenytoin",
          "id": "RxNorm:8183"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "HLA-B",
            "name": "*15:02",
            "function": null,
            "reference": false
          },
          "allele2": {
            "gene": "HLA-B",
            "name": "*57:01",
            "function": null,
            "reference": false
          },
          "gene": "HLA-B",
          "phenotypes": [
            "*15:02 positive",
            "*57:01 positive",
            "*58:01 negative"
          ],
          "variant": null,
          "lookupKey": [
            "*15:02 positive",
            "*57:01 positive",
            "*58:01 negative"
          ],
          "label": "*15:02/*57:01",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "IFNL3",
      "chr": "chr19",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "IFNL3 reverse complement footnote",
          "version": "1",
          "matches": {
            "gene": "IFNL3",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "The IFNL3 gene is on the negative chromosomal strand, all genotype calls for IFNL3 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
        }
      ],
      "relatedDrugs": [
        {
          "name": "peginterferon alfa-2a",
          "id": "RxNorm:120608"
        },
        {
          "name": "peginterferon alfa-2b",
          "id": "RxNorm:253453"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "IFNL3",
            "name": "rs12979860 reference (C)",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "IFNL3",
            "name": "rs12979860 reference (C)",
            "function": null,
            "reference": true
          },
          "gene": "IFNL3",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "rs12979860 reference (C)/rs12979860 reference (C)",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "IFNL3",
            "name": "rs12979860 reference (C)",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "IFNL3",
            "name": "rs12979860 reference (C)",
            "function": null,
            "reference": true
          },
          "gene": "IFNL3",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "rs12979860 reference (C)/rs12979860 reference (C)",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "IFNL3",
          "chromosome": "chr19",
          "position": 39248147,
          "dbSnpId": "rs12979860",
          "call": "C/C",
          "alleles": [
            "rs12979860 variant (T)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "MT-RNR1",
      "chr": null,
      "phased": false,
      "callSource": "OUTSIDE",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "amikacin",
          "id": "RxNorm:641"
        },
        {
          "name": "gentamicin",
          "id": "ATC:D06AX07"
        },
        {
          "name": "kanamycin",
          "id": "RxNorm:6099"
        },
        {
          "name": "paromomycin",
          "id": "RxNorm:7934"
        },
        {
          "name": "plazomicin",
          "id": "RxNorm:2049549"
        },
        {
          "name": "streptomycin",
          "id": "RxNorm:10109"
        },
        {
          "name": "tobramycin",
          "id": "RxNorm:10627"
        }
      ],
      "matcherDiplotypes": [],
      "diplotypes": [
        {
          "allele1": {
            "gene": "MT-RNR1",
            "name": "1555A\u003eG",
            "function": "increased risk of aminoglycoside-induced hearing loss",
            "reference": false
          },
          "allele2": null,
          "gene": "MT-RNR1",
          "phenotypes": [
            "increased risk of aminoglycoside-induced hearing loss"
          ],
          "variant": null,
          "lookupKey": [
            "increased risk of aminoglycoside-induced hearing loss"
          ],
          "label": "1555A\u003eG",
          "geneResult": null
        }
      ],
      "variants": [],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "NUDT15",
      "chr": "chr13",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "azathioprine",
          "id": "RxNorm:1256"
        },
        {
          "name": "mercaptopurine",
          "id": "RxNorm:103"
        },
        {
          "name": "thioguanine",
          "id": "RxNorm:10485"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "NUDT15",
            "name": "*1",
            "function": "Normal Function",
            "reference": true
          },
          "allele2": {
            "gene": "NUDT15",
            "name": "*1",
            "function": "Normal Function",
            "reference": true
          },
          "gene": "NUDT15",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "NUDT15",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "NUDT15",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "NUDT15",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037748,
          "dbSnpId": "rs769369441",
          "call": "T/T",
          "alleles": [
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037749,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037782,
          "dbSnpId": "rs746071566",
          "call": "AGGAGTC/AGGAGTC",
          "alleles": [
            "*2",
            "*6",
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "AGGAGTC",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037798,
          "dbSnpId": "rs186364861",
          "call": "G/G",
          "alleles": [
            "*5"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037825,
          "dbSnpId": "rs777311140",
          "call": "C/C",
          "alleles": [
            "*14"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037834,
          "dbSnpId": "rs1202487323",
          "call": "C/C",
          "alleles": [
            "*16"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037847,
          "dbSnpId": "rs766023281",
          "call": "G/G",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037849,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037885,
          "dbSnpId": "rs1950545307",
          "call": "G/G",
          "alleles": [
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48037902,
          "dbSnpId": "rs149436418",
          "call": "C/C",
          "alleles": [
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48040977,
          "dbSnpId": "rs1457579126",
          "call": "GA/GA",
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "GA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48041103,
          "dbSnpId": "rs761191455",
          "call": "T/T",
          "alleles": [
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48041113,
          "dbSnpId": "rs1368252918",
          "call": "G/G",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045690,
          "dbSnpId": "rs768324690",
          "call": "C/C",
          "alleles": [
            "*20"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045719,
          "dbSnpId": "rs116855232",
          "call": "C/C",
          "alleles": [
            "*2",
            "*3"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045720,
          "dbSnpId": "rs147390019",
          "call": "G/G",
          "alleles": [
            "*4"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "NUDT15",
          "chromosome": "chr13",
          "position": 48045771,
          "dbSnpId": "rs139551410",
          "call": "T/T",
          "alleles": [
            "*15"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "RYR1",
      "chr": "chr19",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "desflurane",
          "id": "RxNorm:27340"
        },
        {
          "name": "enflurane",
          "id": "RxNorm:3920"
        },
        {
          "name": "halothane",
          "id": "RxNorm:5095"
        },
        {
          "name": "isoflurane",
          "id": "RxNorm:6026"
        },
        {
          "name": "methoxyflurane",
          "id": "RxNorm:6857"
        },
        {
          "name": "sevoflurane",
          "id": "RxNorm:36453"
        },
        {
          "name": "succinylcholine",
          "id": "RxNorm:10154"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "RYR1",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "RYR1",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "gene": "RYR1",
          "phenotypes": [
            "Uncertain Susceptibility"
          ],
          "variant": null,
          "lookupKey": [
            "Uncertain Susceptibility"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "RYR1",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "RYR1",
            "name": "Reference",
            "function": "Normal function",
            "reference": true
          },
          "gene": "RYR1",
          "phenotypes": [
            "Uncertain Susceptibility"
          ],
          "variant": null,
          "lookupKey": [
            "Uncertain Susceptibility"
          ],
          "label": "Reference/Reference",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38440802,
          "dbSnpId": "rs193922747",
          "call": "T/T",
          "alleles": [
            "c.103T\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38440829,
          "dbSnpId": "rs193922748",
          "call": "C/C",
          "alleles": [
            "c.130C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38444211,
          "dbSnpId": "rs118192161",
          "call": "C/C",
          "alleles": [
            "c.487C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38444212,
          "dbSnpId": "rs193922753",
          "call": "G/G",
          "alleles": [
            "c.488G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38446710,
          "dbSnpId": "rs1801086",
          "call": "G/G",
          "alleles": [
            "c.742G\u003eA",
            "c.742G\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38448673,
          "dbSnpId": "rs193922762",
          "call": "C/C",
          "alleles": [
            "c.982C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38448712,
          "dbSnpId": "rs121918592",
          "call": "G/G",
          "alleles": [
            "c.1021G\u003eA",
            "c.1021G\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38451842,
          "dbSnpId": "rs193922764",
          "call": "C/C",
          "alleles": [
            "c.1201C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38451850,
          "dbSnpId": "rs118192116",
          "call": "C/C",
          "alleles": [
            "c.1209C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455359,
          "dbSnpId": "rs118192162",
          "call": "A/A",
          "alleles": [
            "c.1565A\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455463,
          "dbSnpId": "rs111888148",
          "call": "G/G",
          "alleles": [
            "c.1589G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455471,
          "dbSnpId": "rs193922768",
          "call": "C/C",
          "alleles": [
            "c.1597C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455472,
          "dbSnpId": "rs144336148",
          "call": "G/G",
          "alleles": [
            "c.1598G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38455528,
          "dbSnpId": "rs193922770",
          "call": "C/C",
          "alleles": [
            "c.1654C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38457545,
          "dbSnpId": "rs118192172",
          "call": "C/C",
          "alleles": [
            "c.1840C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38457546,
          "dbSnpId": "rs193922772",
          "call": "G/G",
          "alleles": [
            "c.1841G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494564,
          "dbSnpId": "rs118192175",
          "call": "C/C",
          "alleles": [
            "c.6487C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494565,
          "dbSnpId": "rs118192163",
          "call": "G/G",
          "alleles": [
            "c.6488G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38494579,
          "dbSnpId": "rs118192176",
          "call": "G/G",
          "alleles": [
            "c.6502G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38496283,
          "dbSnpId": "rs118192177",
          "call": "C/C",
          "alleles": [
            "c.6617C\u003eG",
            "c.6617C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499223,
          "dbSnpId": "rs112563513",
          "call": "G/G",
          "alleles": [
            "c.7007G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499644,
          "dbSnpId": "rs121918596",
          "call": "TGGA/TGGA",
          "alleles": [
            "c.7042_7044delGAG"
          ],
          "phased": false,
          "wildtypeAllele": "TGGA",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499655,
          "dbSnpId": "rs193922802",
          "call": "G/G",
          "alleles": [
            "c.7048G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499670,
          "dbSnpId": "rs193922803",
          "call": "C/C",
          "alleles": [
            "c.7063C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499731,
          "dbSnpId": "rs193922807",
          "call": "G/G",
          "alleles": [
            "c.7124G\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499975,
          "dbSnpId": "rs193922809",
          "call": "G/G",
          "alleles": [
            "c.7282G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499993,
          "dbSnpId": "rs121918593",
          "call": "G/G",
          "alleles": [
            "c.7300G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38499997,
          "dbSnpId": "rs28933396",
          "call": "G/G",
          "alleles": [
            "c.7304G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500636,
          "dbSnpId": "rs118192124",
          "call": "C/C",
          "alleles": [
            "c.7354C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500642,
          "dbSnpId": "rs193922816",
          "call": "C/C",
          "alleles": [
            "c.7360C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500643,
          "dbSnpId": "rs118192122",
          "call": "G/G",
          "alleles": [
            "c.7361G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500654,
          "dbSnpId": "rs28933397",
          "call": "C/C",
          "alleles": [
            "c.7372C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500655,
          "dbSnpId": "rs121918594",
          "call": "G/G",
          "alleles": [
            "c.7373G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500898,
          "dbSnpId": "rs118192178",
          "call": "C/C",
          "alleles": [
            "c.7522C\u003eG",
            "c.7522C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38500899,
          "dbSnpId": "rs193922818",
          "call": "G/G",
          "alleles": [
            "c.7523G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38512321,
          "dbSnpId": "rs193922832",
          "call": "G/G",
          "alleles": [
            "c.9310G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38543832,
          "dbSnpId": "rs193922843",
          "call": "G/G",
          "alleles": [
            "c.11969G\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580004,
          "dbSnpId": "rs118192167",
          "call": "A/A",
          "alleles": [
            "c.14387A\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580094,
          "dbSnpId": "rs121918595",
          "call": "C/C",
          "alleles": [
            "c.14477C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580114,
          "dbSnpId": "rs193922876",
          "call": "C/C",
          "alleles": [
            "c.14497C\u003eT"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580370,
          "dbSnpId": "rs193922878",
          "call": "C/C",
          "alleles": [
            "c.14512C\u003eG"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580403,
          "dbSnpId": "rs118192168",
          "call": "G/G",
          "alleles": [
            "c.14545G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38580440,
          "dbSnpId": "rs63749869",
          "call": "G/G",
          "alleles": [
            "c.14582G\u003eA"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "RYR1",
          "chromosome": "chr19",
          "position": 38584989,
          "dbSnpId": "rs118192170",
          "call": "T/T",
          "alleles": [
            "c.14693T\u003eC"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "SLCO1B1",
      "chr": "chr12",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [
        "*38",
        "*41",
        "*45"
      ],
      "messages": [],
      "relatedDrugs": [
        {
          "name": "atorvastatin",
          "id": "RxNorm:83367"
        },
        {
          "name": "fluvastatin",
          "id": "RxNorm:41127"
        },
        {
          "name": "lovastatin",
          "id": "RxNorm:6472"
        },
        {
          "name": "pitavastatin",
          "id": "RxNorm:861634"
        },
        {
          "name": "pravastatin",
          "id": "RxNorm:42463"
        },
        {
          "name": "rosuvastatin",
          "id": "RxNorm:301542"
        },
        {
          "name": "simvastatin",
          "id": "RxNorm:36567"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "SLCO1B1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "SLCO1B1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "SLCO1B1",
          "phenotypes": [
            "Normal Function"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Function"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "SLCO1B1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "SLCO1B1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "SLCO1B1",
          "phenotypes": [
            "Normal Function"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Function"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172734,
          "dbSnpId": "rs139257324",
          "call": "C/C",
          "alleles": [
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172776,
          "dbSnpId": "rs373327528",
          "call": "G/G",
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21172782,
          "dbSnpId": "rs56101265",
          "call": "T/T",
          "alleles": [
            "*2",
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21174595,
          "dbSnpId": "rs56061388",
          "call": "T/T",
          "alleles": [
            "*3",
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176804,
          "dbSnpId": "rs2306283",
          "call": "A/A",
          "alleles": [
            "*14",
            "*15",
            "*20",
            "*24",
            "*25",
            "*27",
            "*28",
            "*29",
            "*30",
            "*31",
            "*32",
            "*33",
            "*37",
            "*39",
            "*42",
            "*43",
            "*44",
            "*46",
            "*47"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176868,
          "dbSnpId": "rs2306282",
          "call": "A/A",
          "alleles": [
            "*16"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176879,
          "dbSnpId": "rs11045819",
          "call": "C/C",
          "alleles": [
            "*4",
            "*14",
            "*25",
            "*32",
            "*43"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176883,
          "dbSnpId": "rs72559745",
          "call": "A/A",
          "alleles": [
            "*3",
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178615,
          "dbSnpId": "rs4149056",
          "call": "T/T",
          "alleles": [
            "*5",
            "*15",
            "*40",
            "*46",
            "*47"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178957,
          "dbSnpId": "rs79135870",
          "call": "A/A",
          "alleles": [
            "*30"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196951,
          "dbSnpId": "rs11045852",
          "call": "A/A",
          "alleles": [
            "*24",
            "*25",
            "*28",
            "*32",
            "*33",
            "*43",
            "*44"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196976,
          "dbSnpId": "rs11045853",
          "call": "G/G",
          "alleles": [
            "*25",
            "*28",
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21200595,
          "dbSnpId": "rs55901008",
          "call": "T/T",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202553,
          "dbSnpId": "rs1228465562",
          "call": "T/T",
          "alleles": [
            "*36"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202555,
          "dbSnpId": "rs59113707",
          "call": "C/C",
          "alleles": [
            "*27"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202649,
          "dbSnpId": "rs56387224",
          "call": "A/A",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21202664,
          "dbSnpId": "rs142965323",
          "call": "G/G",
          "alleles": [
            "*26"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21205921,
          "dbSnpId": "rs72559748",
          "call": "A/A",
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21205999,
          "dbSnpId": "rs59502379",
          "call": "G/G",
          "alleles": [
            "*9",
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239042,
          "dbSnpId": "rs34671512",
          "call": "A/A",
          "alleles": [
            "*19",
            "*20",
            "*40"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239077,
          "dbSnpId": "rs56199088",
          "call": "A/A",
          "alleles": [
            "*10",
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239113,
          "dbSnpId": "rs55737008",
          "call": "A/A",
          "alleles": [
            "*11",
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239145,
          "dbSnpId": "rs200995543",
          "call": "C/C",
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21239158,
          "dbSnpId": "rs140790673",
          "call": "C/C",
          "alleles": [
            "*29"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176871,
          "dbSnpId": null,
          "call": null,
          "alleles": [
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21176898,
          "dbSnpId": "rs77271279",
          "call": null,
          "alleles": [
            "*41"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21178612,
          "dbSnpId": "rs141467543",
          "call": null,
          "alleles": [
            "*42"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21196975,
          "dbSnpId": "rs183501729",
          "call": null,
          "alleles": [
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21200544,
          "dbSnpId": "rs72559747",
          "call": null,
          "alleles": [
            "*47"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21206031,
          "dbSnpId": "rs74064213",
          "call": null,
          "alleles": [
            "*43",
            "*44"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "SLCO1B1",
          "chromosome": "chr12",
          "position": 21222355,
          "dbSnpId": "rs71581941",
          "call": null,
          "alleles": [
            "*45",
            "*46"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": [
        "rs4149056T/rs4149056T"
      ]
    },
    {
      "geneSymbol": "TPMT",
      "chr": "chr6",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "TPMT reverse complement footnote",
          "version": "1",
          "matches": {
            "gene": "TPMT",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "The TPMT gene is on the negative chromosomal strand, all genotype calls for TPMT in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
        }
      ],
      "relatedDrugs": [
        {
          "name": "azathioprine",
          "id": "RxNorm:1256"
        },
        {
          "name": "mercaptopurine",
          "id": "RxNorm:103"
        },
        {
          "name": "thioguanine",
          "id": "RxNorm:10485"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "TPMT",
            "name": "*1",
            "function": "Normal Function",
            "reference": true
          },
          "allele2": {
            "gene": "TPMT",
            "name": "*1",
            "function": "Normal Function",
            "reference": true
          },
          "gene": "TPMT",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "TPMT",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "TPMT",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "TPMT",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130687,
          "dbSnpId": "rs1142345",
          "call": "T/T",
          "alleles": [
            "*3A",
            "*3C",
            "*41"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130694,
          "dbSnpId": "rs150900439",
          "call": "T/T",
          "alleles": [
            "*20"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130725,
          "dbSnpId": "rs72552736",
          "call": "A/A",
          "alleles": [
            "*7"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130729,
          "dbSnpId": "rs139392616",
          "call": "C/C",
          "alleles": [
            "*40"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130758,
          "dbSnpId": "rs398122996",
          "call": "A/A",
          "alleles": [
            "*37"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130762,
          "dbSnpId": "rs56161402",
          "call": "C/C",
          "alleles": [
            "*8"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130772,
          "dbSnpId": "rs377085266",
          "call": "A/A",
          "alleles": [
            "*25"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18130781,
          "dbSnpId": "rs1800584",
          "call": "C/C",
          "alleles": [
            "*4"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132136,
          "dbSnpId": "rs72556347",
          "call": "A/A",
          "alleles": [
            "*26"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132147,
          "dbSnpId": "rs79901429",
          "call": "A/A",
          "alleles": [
            "*31"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18132163,
          "dbSnpId": null,
          "call": "C/C",
          "alleles": [
            "*36"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133845,
          "dbSnpId": "rs75543815",
          "call": "T/T",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133847,
          "dbSnpId": "rs6921269",
          "call": "C/C",
          "alleles": [
            "*24"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133870,
          "dbSnpId": "rs772832951",
          "call": "A/A",
          "alleles": [
            "*38"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133884,
          "dbSnpId": "rs74423290",
          "call": "G/G",
          "alleles": [
            "*23"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133887,
          "dbSnpId": "rs201695576",
          "call": "T/T",
          "alleles": [
            "*44"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18133890,
          "dbSnpId": "rs9333570",
          "call": "C/C",
          "alleles": [
            "*15"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138969,
          "dbSnpId": "rs144041067",
          "call": "C/C",
          "alleles": [
            "*16",
            "*22"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138970,
          "dbSnpId": "rs112339338",
          "call": "G/G",
          "alleles": [
            "*33"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18138997,
          "dbSnpId": "rs1800460",
          "call": "C/C",
          "alleles": [
            "*3A",
            "*3B"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139027,
          "dbSnpId": "rs72552737",
          "call": "C/C",
          "alleles": [
            "*10"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139689,
          "dbSnpId": "rs72552738",
          "call": "C/C",
          "alleles": [
            "*11"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18139710,
          "dbSnpId": "rs200220210",
          "call": "G/G",
          "alleles": [
            "*12"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143597,
          "dbSnpId": null,
          "call": "T/T",
          "alleles": [
            "*19"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143606,
          "dbSnpId": "rs151149760",
          "call": "T/T",
          "alleles": [
            "*9"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143613,
          "dbSnpId": null,
          "call": "C/C",
          "alleles": [
            "*28"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143622,
          "dbSnpId": "rs115106679",
          "call": "C/C",
          "alleles": [
            "*32"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143643,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*27"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143700,
          "dbSnpId": "rs753545734",
          "call": "C/C",
          "alleles": [
            "*43"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143718,
          "dbSnpId": "rs111901354",
          "call": "G/G",
          "alleles": [
            "*34"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143724,
          "dbSnpId": "rs1800462",
          "call": "C/C",
          "alleles": [
            "*2"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18143728,
          "dbSnpId": "rs1256618794",
          "call": "C/C",
          "alleles": [
            "*43"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147838,
          "dbSnpId": "rs281874771",
          "call": "G/G",
          "alleles": [
            "*39"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147845,
          "dbSnpId": "rs777686348",
          "call": "C/C",
          "alleles": [
            "*18"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147851,
          "dbSnpId": "rs200591577",
          "call": "G/G",
          "alleles": [
            "*21"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147856,
          "dbSnpId": null,
          "call": "A/A",
          "alleles": [
            "*35"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18147910,
          "dbSnpId": "rs72552740",
          "call": "A/A",
          "alleles": [
            "*5"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149004,
          "dbSnpId": null,
          "call": "G/G",
          "alleles": [
            "*17"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149022,
          "dbSnpId": "rs750424422",
          "call": "C/C",
          "alleles": [
            "*30"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149032,
          "dbSnpId": "rs759836180",
          "call": "C/C",
          "alleles": [
            "*42"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149045,
          "dbSnpId": "rs72552742",
          "call": "T/T",
          "alleles": [
            "*13"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149126,
          "dbSnpId": "rs267607275",
          "call": "A/A",
          "alleles": [
            "*29"
          ],
          "phased": false,
          "wildtypeAllele": "A",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "TPMT",
          "chromosome": "chr6",
          "position": 18149127,
          "dbSnpId": "rs9333569",
          "call": "T/T",
          "alleles": [
            "*14"
          ],
          "phased": false,
          "wildtypeAllele": "T",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "UGT1A1",
      "chr": "chr2",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "UGT1A1 repeat warning",
          "version": "1",
          "matches": {
            "gene": "UGT1A1",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "Some alleles in UGT1A1 are distinguished by a repeat sequence; some genotyping technologies may not accurately call the repeat."
        }
      ],
      "relatedDrugs": [
        {
          "name": "atazanavir",
          "id": "RxNorm:343047"
        },
        {
          "name": "irinotecan",
          "id": "PA166104951"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "UGT1A1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "UGT1A1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "UGT1A1",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "UGT1A1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "allele2": {
            "gene": "UGT1A1",
            "name": "*1",
            "function": "Normal function",
            "reference": true
          },
          "gene": "UGT1A1",
          "phenotypes": [
            "Normal Metabolizer"
          ],
          "variant": null,
          "lookupKey": [
            "Normal Metabolizer"
          ],
          "label": "*1/*1",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233759924,
          "dbSnpId": "rs887829",
          "call": "C/C",
          "alleles": [
            "*80",
            "*80+*28",
            "*80+*37"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760233,
          "dbSnpId": "rs3064744",
          "call": "CAT/CAT",
          "alleles": [
            "*28",
            "*36",
            "*37",
            "*80+*28",
            "*80+*37"
          ],
          "phased": false,
          "wildtypeAllele": "CAT",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760498,
          "dbSnpId": "rs4148323",
          "call": "G/G",
          "alleles": [
            "*6"
          ],
          "phased": false,
          "wildtypeAllele": "G",
          "mismatch": false,
          "warnings": []
        },
        {
          "gene": "UGT1A1",
          "chromosome": "chr2",
          "position": 233760973,
          "dbSnpId": "rs35350960",
          "call": "C/C",
          "alleles": [
            "*27"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    },
    {
      "geneSymbol": "VKORC1",
      "chr": "chr16",
      "phased": false,
      "callSource": "MATCHER",
      "uncalledHaplotypes": [],
      "messages": [
        {
          "rule_name": "VKORC1",
          "version": "1",
          "matches": {
            "gene": "VKORC1",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "CPIC recommendations for warfarin use only rs9923231; however, other variants in VKORC1 may have functional consequences and may be more common in some populations."
        },
        {
          "rule_name": "VKORC1 reverse complement footnote",
          "version": "1",
          "matches": {
            "gene": "VKORC1",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": []
          },
          "exception_type": "footnote",
          "message": "The VKORC1 gene is on the negative chromosomal strand, all genotype calls for VKORC1 in this report refer to the positive chromosomal strand.  Therefore, genotype calls are complemented from gene bases."
        }
      ],
      "relatedDrugs": [
        {
          "name": "acenocoumarol",
          "id": "PA166104938"
        },
        {
          "name": "phenprocoumon",
          "id": "PA166104940"
        },
        {
          "name": "warfarin",
          "id": "RxNorm:11289"
        }
      ],
      "matcherDiplotypes": [
        {
          "allele1": {
            "gene": "VKORC1",
            "name": "rs9923231 reference (C)",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "VKORC1",
            "name": "rs9923231 reference (C)",
            "function": null,
            "reference": true
          },
          "gene": "VKORC1",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "rs9923231 reference (C)/rs9923231 reference (C)",
          "geneResult": null
        }
      ],
      "diplotypes": [
        {
          "allele1": {
            "gene": "VKORC1",
            "name": "rs9923231 reference (C)",
            "function": null,
            "reference": true
          },
          "allele2": {
            "gene": "VKORC1",
            "name": "rs9923231 reference (C)",
            "function": null,
            "reference": true
          },
          "gene": "VKORC1",
          "phenotypes": [],
          "variant": null,
          "lookupKey": [],
          "label": "rs9923231 reference (C)/rs9923231 reference (C)",
          "geneResult": null
        }
      ],
      "variants": [
        {
          "gene": "VKORC1",
          "chromosome": "chr16",
          "position": 31096368,
          "dbSnpId": "rs9923231",
          "call": "C/C",
          "alleles": [
            "rs9923231 variant (T)"
          ],
          "phased": false,
          "wildtypeAllele": "C",
          "mismatch": false,
          "warnings": []
        }
      ],
      "variantsOfInterest": [],
      "highlightedVariants": []
    }
  ],
  "drugs": [
    {
      "name": "abacavir",
      "cpicId": "RxNorm:190521",
      "pharmgkbId": "PA166104991",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-abacavir-and-hla-b/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104991"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing",
          "authors": [
            "Martin M A",
            "Klein T E",
            "Dong B J",
            "Pirmohamed M",
            "Haas D W",
            "Kroetz D L"
          ],
          "pmid": "22378157",
          "pmcid": "PMC3374459",
          "doi": "10.1038/clpt.2011.355",
          "month": 2,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update",
          "authors": [
            "Martin Michael A",
            "Hoffman James M",
            "Freimuth Robert R",
            "Klein Teri E",
            "Dong Betty J",
            "Pirmohamed Munir",
            "Hicks J Kevin",
            "Wilkinson Mark R",
            "Haas David W",
            "Kroetz Deanna L"
          ],
          "pmid": "24561393",
          "pmcid": "PMC3994233",
          "doi": "10.1038/clpt.2014.38",
          "month": 2,
          "year": 2014
        }
      ],
      "guidelines": [
        {
          "name": "HLA-B and Abacavir",
          "id": "RxNorm:190521",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-abacavir-and-hla-b/",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "Significantly increased risk of abacavir hypersensitivity"
              },
              "drugRecommendation": "Abacavir is not recommended",
              "classification": "Strong",
              "phenotypes": {},
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for abacavir and HLA-B",
          "id": "PA166104991",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104991",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "HLA-B*57:01-positive patients have a strongly increased risk of a hypersensitivity reaction to abacavir. 48% of the HLA-B*57:01-positive patients develop a severe and potentially life-threatening hypersensitivity reaction to abacavir"
              },
              "drugRecommendation": "Abacavir is contra-indicated for HLA-B*57:01-positive patients.\n\u003col\u003e\n\u003cli\u003eAvoid abacavir.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "acenocoumarol",
      "cpicId": null,
      "pharmgkbId": "PA166104938",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104938"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for acenocoumarol and VKORC1",
          "id": "PA166104938",
          "source": "DPWG",
          "version": "30",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104938",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "allopurinol",
      "cpicId": "RxNorm:519",
      "pharmgkbId": "PA166265141",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define ABCG2 alleles is missing which may change the matched genotype. See the gene section for ABCG2 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-allopurinol-and-hla-b/",
        "https://pharmgkb.org/guidelineAnnotation/PA166264961",
        "https://pharmgkb.org/guidelineAnnotation/PA166265141"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update",
          "authors": [
            "Saito Y",
            "Stamp L K",
            "Caudle K E",
            "Hershfield M S",
            "McDonagh E M",
            "Callaghan J T",
            "Tassaneeyakul W",
            "Mushiroda T",
            "Kamatani N",
            "Goldspiel B R",
            "Phillips E J",
            "Klein T E",
            "Lee Mtm"
          ],
          "pmid": "26094938",
          "pmcid": "PMC4675696",
          "doi": "10.1002/cpt.161",
          "month": 6,
          "year": 2015
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing",
          "authors": [
            "Hershfield M S",
            "Callaghan J T",
            "Tassaneeyakul W",
            "Mushiroda T",
            "Thorn C F",
            "Klein T E",
            "Lee M T M"
          ],
          "pmid": "23232549",
          "pmcid": "PMC3564416",
          "doi": "10.1038/clpt.2012.209",
          "month": 10,
          "year": 2012
        }
      ],
      "guidelines": [
        {
          "name": "HLA-B and Allopurinol",
          "id": "RxNorm:519",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-allopurinol-and-hla-b/",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "Low or reduced risk of allopurinol-induced SCAR"
              },
              "drugRecommendation": "Use allopurinol per standard dosing guidelines",
              "classification": "Strong",
              "phenotypes": {},
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for allopurinol and ABCG2",
          "id": "PA166264961",
          "source": "DPWG",
          "version": "7",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166264961",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for allopurinol and HLA-B",
          "id": "PA166265141",
          "source": "DPWG",
          "version": "3",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265141",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "The guideline does not provide a description of the impact of the absence of HLA-B*58:01 alleles on allopurinol."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for allopurinol in patients with no HLA-B*58:01 alleles or negative for the HLA-B*58:01 test.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "amikacin",
      "cpicId": "RxNorm:641",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:641",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "amitriptyline",
      "cpicId": "RxNorm:704",
      "pharmgkbId": "PA166104982",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104982"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:704",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism of tertiary amines",
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects"
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer",
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a",
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for amitriptyline and CYP2D6",
          "id": "PA166104982",
          "source": "DPWG",
          "version": "26",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104982",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects is increased, because the gene variation leads to higher plasma concentrations of the active metabolite nortriptyline and to a lesser extent of amitriptyline."
              },
              "drugRecommendation": "Use 75% of the standard dose and monitor the efficacy and side effects or the plasma concentrations of amitriptyline and nortriptyline to adjust the maintenance dose",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "aripiprazole",
      "cpicId": null,
      "pharmgkbId": "PA166104937",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104937"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for aripiprazole and CYP2D6",
          "id": "PA166104937",
          "source": "DPWG",
          "version": "30",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104937",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The guideline does not provide a description of the impact of an intermediate metabolizer phenotype on aripiprazole."
              },
              "drugRecommendation": "NO action is needed for this gene-drug interaction.The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "atazanavir",
      "cpicId": "RxNorm:343047",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing",
          "authors": [
            "Gammal Roseann S",
            "Court Michael H",
            "Haidar Cyrine E",
            "Iwuchukwu Otito Frances",
            "Gaur Aditya H",
            "Alvarellos Maria",
            "Guillemette Chantal",
            "Lennox Jeffrey L",
            "Whirl-Carrillo Michelle",
            "Brummel Sean",
            "Ratain Mark J",
            "Klein Teri E",
            "Schackman Bruce R",
            "Caudle Kelly E",
            "Haas David W"
          ],
          "pmid": "26417955",
          "pmcid": "PMC4785051",
          "doi": "10.1002/cpt.269",
          "month": 9,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "UGT1A1 and Atazanavir",
          "id": "RxNorm:343047",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-atazanavir-and-ugt1a1/",
          "annotationGroups": [
            {
              "implications": {
                "UGT1A1": "Reference UGT1A1 activity; very low likelihood of bilirubin-related discontinuation of atazanavir."
              },
              "drugRecommendation": "There is no need to avoid prescribing of atazanavir based on UGT1A1 genetic test result. Inform the patient that some patients stop atazanavir because of jaundice (yellow eyes and skin), but that this patients genotype makes this unlikely (less than about a 1 in 20 chance of stopping atazanavir because of jaundice).",
              "classification": "Strong",
              "phenotypes": {
                "UGT1A1": "Normal Metabolizer"
              },
              "activityScore": {
                "UGT1A1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "UGT1A1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "UGT1A1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "UGT1A1",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "All studies correlating UGT1A1 genotypes with atazanavir adverse events have involved ritonavir boosting. However, concentration-time profiles are equivalent when boosted with either cobicistat or ritonavir (PMID 23532097), and bilirubin-related adverse events including discontinuation of atazanavir occur in a similar percentage of patients prescribed atazanavir with cobicistat or ritonavir (PMID 23532097). Associations between UGT1A1 genotype, bilirubin elevations, and atazanavir/r discontinuation therefore almost certainly translate to atazanavir/cobicistat. \"reference\" function refers to the UGT1A1 allele to which other alleles are compared."
            }
          ]
        }
      ]
    },
    {
      "name": "atomoxetine",
      "cpicId": "RxNorm:38400",
      "pharmgkbId": "PA166104989",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104989"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.",
          "authors": [
            "Brown Jacob T",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Nurmi Erika L",
            "Mueller Daniel J",
            "Dinh Jean C",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Caudle Kelly E",
            "McCracken James T",
            "de Leon Jose",
            "Steven Leeder J"
          ],
          "pmid": "30801677",
          "pmcid": null,
          "doi": null,
          "month": 2,
          "year": 2019
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6 and Atomoxetine",
          "id": "RxNorm:38400",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-atomoxetine-based-on-cyp2d6-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Possibly higher atomoxetine concentrations as compared to normal metabolizers but questionable clinical significance. Intermediate metabolizers with an activity score of 1 may be at an increased risk of discontinuation as compared to poor metabolizers."
              },
              "drugRecommendation": "Initiate with a dose of 0.5 mg/kg/day and increase to 1.2 mg/kg/day after 3 days. If no clinical response and in the absence of adverse events after 2 weeks, consider obtaining a peak plasma concentration (1 to 2 hours after dose administered). If \u003c 200 ng/mL, consider a proportional increase in dose to approach 400 ng/mL.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "pediatrics",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Therapeutic range of 200 to 1000 ng/mL has been proposed (PMID 29493375). Limited data are available regarding the relationship between atomoxetine plasma concentrations and clinical response. Available information suggests that clinical response is greater in poor metabolizers (PMs) compared to non-PMs and may be related to the higher plasma concentrations 1 to 1.5 hours after dosing in PMs compared to non-PMs administered a similar dose. Furthermore, modest improvement in response, defined as reduction in ADHD-rating scale, is observed at peak concentrations greater than 400 ng/mL."
            },
            {
              "implications": {
                "CYP2D6": "Possibly higher atomoxetine concentrations as compared to normal metabolizers but questionable clinical significance. Intermediate metabolizers with an activity score of 1 may be at an increased risk of discontinuation as compared to poor metabolizers."
              },
              "drugRecommendation": "Initiate with a dose of 40 mg/day and increase to 80 mg/day after 3 days. If no clinical response and in the absence of adverse events after 2 weeks, consider increasing dose to 100 mg/day. If no clinical response observed after 2 weeks, consider obtaining a peak plasma concentration (1 to 2 hours after dose administered). If \u003c200 ng/mL, consider a proportional increase in dose to approach 400 ng/mL. Dosages greater than 100 mg/day may be needed to achieve target concentrations.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "adults",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Therapeutic range of 200 to 1000 ng/mL has been proposed (PMID 29493375). Limited data are available regarding the relationship between atomoxetine plasma concentrations and clinical response. Available information suggests that clinical response is greater in poor metabolizers (PMs) compared to non-PMs and may be related to the higher plasma concentrations 1 to 1.5 hours after dosing in PMs compared to non-PMs administered a similar dose. Furthermore, modest improvement in response, defined as reduction in ADHD-rating scale, is observed at peak concentrations greater than 400 ng/mL. Doses above 120 mg/day have not been evaluated."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for atomoxetine and CYP2D6",
          "id": "PA166104989",
          "source": "DPWG",
          "version": "23",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104989",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The genetic variation increases the plasma concentration of atomoxetine and can thereby reduce the dose requirement."
              },
              "drugRecommendation": "\u003col\u003e\n\u003cli\u003eIn the event of side effects occurring and/or a response later than 9 weeks: reduce the dose and check whether the effect is conserved. The plasma concentration of atomoxetine is a factor of 2-3 times higher for IM than for EM at the same dose.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "atorvastatin",
      "cpicId": "RxNorm:83367",
      "pharmgkbId": "PA166182843",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
        "https://pharmgkb.org/guidelineAnnotation/PA166182843"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:83367",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "population general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for atorvastatin and SLCO1B1",
          "id": "PA166182843",
          "source": "DPWG",
          "version": "8",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182843",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "azathioprine",
      "cpicId": "RxNorm:1256",
      "pharmgkbId": "PA166104934",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
        "https://pharmgkb.org/guidelineAnnotation/PA166184614",
        "https://pharmgkb.org/guidelineAnnotation/PA166104934"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "TPMT, NUDT15 and Thiopurines",
          "id": "RxNorm:1256",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
                "TPMT": "Lower concentrations of TGN metabolites, higher MeTIMP, this is the normal pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression."
              },
              "drugRecommendation": "Start with normal starting dose (e.g., 2-3 mg/kg/day) and adjust doses of azathioprine based on disease-specific guidelines. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11302950, 15606506).",
              "classification": "Strong",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer",
                "TPMT": "Normal Metabolizer"
              },
              "activityScore": {
                "NUDT15": "n/a",
                "TPMT": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "TPMT",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for azathioprine and NUDT15",
          "id": "PA166184614",
          "source": "DPWG",
          "version": "6",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166184614",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for azathioprine in normal metabolizers",
              "classification": "N/A",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for azathioprine and TPMT",
          "id": "PA166104934",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104934",
          "annotationGroups": [
            {
              "implications": {
                "TPMT": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on azathioprine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for azathioprine in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "TPMT": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "TPMT",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "brexpiprazole",
      "cpicId": null,
      "pharmgkbId": "PA166184527",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166184527"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for brexpiprazole and CYP2D6",
          "id": "PA166184527",
          "source": "DPWG",
          "version": "5",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166184527",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The guideline does not provide a description of the impact of an intermediate metabolizer phenotype on brexpiprazole."
              },
              "drugRecommendation": "NO action is required for this gene-drug interaction. There are indications supporting an increase in the exposure to brexpiprazole, but no indications supporting an increase in side effects in patients with this gene variation.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "capecitabine",
      "cpicId": "RxNorm:194000",
      "pharmgkbId": "PA166104963",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104963"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "23988873",
          "pmcid": "PMC3831181",
          "doi": "10.1038/clpt.2013.172",
          "month": 8,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
          "authors": [
            "Amstutz Ursula",
            "Henricks Linda M",
            "Offer Steven M",
            "Barbarino Julia",
            "Schellens Jan H M",
            "Swen Jesse J",
            "Klein Teri E",
            "McLeod Howard L",
            "Caudle Kelly E",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "29152729",
          "pmcid": "PMC5760397",
          "doi": "10.1002/cpt.911",
          "month": 11,
          "year": 2017
        }
      ],
      "guidelines": [
        {
          "name": "DPYD and Fluoropyrimidines",
          "id": "RxNorm:194000",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "Normal DPD activity and \"normal\" risk for fluoropyrimidine toxicity"
              },
              "drugRecommendation": "Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.",
              "classification": "Strong",
              "phenotypes": {
                "DPYD": "Normal Metabolizer"
              },
              "activityScore": {
                "DPYD": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for capecitabine and DPYD",
          "id": "PA166104963",
          "source": "DPWG",
          "version": "27",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104963",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "The guideline does not provide a description of the impact of a \u003cem\u003eDPYD\u003c/em\u003e activity score of 2 on capecitabine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for capecitabine in patients with a \u003cem\u003eDPYD\u003c/em\u003e activity score of 2.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {
                "DPYD": "2"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "carbamazepine",
      "cpicId": "RxNorm:2002",
      "pharmgkbId": "PA166265162",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/",
        "https://pharmgkb.org/guidelineAnnotation/PA166265161",
        "https://pharmgkb.org/guidelineAnnotation/PA166265162"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing",
          "authors": [
            "Leckband Susan G",
            "Kelsoe John R",
            "Dunnenberger H Mark",
            "George Alfred L",
            "Tran Eric",
            "Berger Reisel",
            "Mller Daniel J",
            "Whirl-Carrillo Michelle",
            "Caudle Kelly E",
            "Pirmohamed Munir"
          ],
          "pmid": "23695185",
          "pmcid": "PMC3748365",
          "doi": "10.1038/clpt.2013.103",
          "month": 5,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.",
          "authors": [
            "Phillips Elizabeth J",
            "Sukasem Chonlaphat",
            "Whirl-Carrillo Michelle",
            "Mller Daniel J",
            "Dunnenberger Henry M",
            "Chantratita Wasun",
            "Goldspiel Barry",
            "Chen Yuan-Tsong",
            "Carleton Bruce C",
            "George Alfred L",
            "Mushiroda Taisei",
            "Klein Teri",
            "Gammal Roseann S",
            "Pirmohamed Munir"
          ],
          "pmid": "29392710",
          "pmcid": "PMC5847474",
          "doi": "10.1002/cpt.1004",
          "month": 4,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "HLA-A, HLA-B and Carbamazepine and Oxcarbazepine",
          "id": "RxNorm:2002",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for carbamazepine and HLA-A",
          "id": "PA166265161",
          "source": "DPWG",
          "version": "4",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265161",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for carbamazepine and HLA-B",
          "id": "PA166265162",
          "source": "DPWG",
          "version": "3",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265162",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "Patients with this genetic variation have a severely increased risk of experiencing the life-threatening cutaneous adverse event Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). The risk of carbamazepine-induced SJS/TEN in these patients is 1.8-3.4%."
              },
              "drugRecommendation": "\u003cul\u003e\n\u003cli\u003eChoose an alternative if possible. Phenytoin, lamotrigine and oxcarbazepine also pose an increased risk of SJS/TEN in these patients, but the final risk is 10-fold lower for these medicines than for carbamazepine. Furthermore, in the case of oxcarbazepine, the most severe forms (SJS/TEN overlap and TEN) have not been observed.\u003c/li\u003e\n\u003c/ul\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "celecoxib",
      "cpicId": "RxNorm:140587",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:140587",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "citalopram",
      "cpicId": "RxNorm:2556",
      "pharmgkbId": "PA166104977",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104977"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Mller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrin",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors",
          "id": "RxNorm:2556",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for citalopram and CYP2C19",
          "id": "PA166104977",
          "source": "DPWG",
          "version": "31",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104977",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "clomipramine",
      "cpicId": "RxNorm:2597",
      "pharmgkbId": "PA166104964",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166184528",
        "https://pharmgkb.org/guidelineAnnotation/PA166104964"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:2597",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism of tertiary amines",
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects"
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer",
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a",
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for clomipramine and CYP2C19",
          "id": "PA166184528",
          "source": "DPWG",
          "version": "6",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166184528",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for clomipramine and CYP2D6",
          "id": "PA166104964",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104964",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of clomipramine and the active metabolite desmethylclomipramine."
              },
              "drugRecommendation": "Use 70% of the standard dose and monitor the effect and side effects or the plasma concentrations of clomipramine and desmethylclomipramine. For depression, the therapeutic range is 200-400 ng/mL for the sum of the plasma concentrations of clomipramine and desmethylclomipramine. For anxiety disorders, the therapeutic plasma concentration of clomipramine is approximately 100 ng/mL, in combination with a plasma concentration of desmethylclomipramine lower than 200 ng/mL. For obsessive compulsive disorder, the therapeutic plasma concentration of clomipramine is higher than 200 ng/mL, in combination with a plasma concentration of desmethylclomipramine that is as low as possible. A sum of the plasma concentrations of clomipramine and desmethylclomipramine higher than 600 ng/mL is considered toxic.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "clopidogrel",
      "cpicId": "RxNorm:32968",
      "pharmgkbId": "PA166104956",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104956"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy",
          "authors": [
            "Scott S A",
            "Sangkuhl K",
            "Gardner E E",
            "Stein C M",
            "Hulot J-S",
            "Johnson J A",
            "Roden D M",
            "Klein T E",
            "Shuldiner A R"
          ],
          "pmid": "21716271",
          "pmcid": "PMC3234301",
          "doi": "10.1038/clpt.2011.132",
          "month": 6,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update",
          "authors": [
            "Scott Stuart A",
            "Sangkuhl Katrin",
            "Stein C Michael",
            "Hulot Jean-Sbastien",
            "Mega Jessica L",
            "Roden Dan M",
            "Klein Teri E",
            "Sabatine Marc S",
            "Johnson Julie A",
            "Shuldiner Alan R"
          ],
          "pmid": "23698643",
          "pmcid": "PMC3748366",
          "doi": "10.1038/clpt.2013.105",
          "month": 5,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.",
          "authors": [
            "Lee Craig R",
            "Luzum Jasmine A",
            "Sangkuhl Katrin",
            "Gammal Roseann S",
            "Sabatine Marc S",
            "Stein C Michael",
            "Kisor David F",
            "Limdi Nita A",
            "Lee Yee Ming",
            "Scott Stuart A",
            "Hulot Jean-Sbastien",
            "Roden Dan M",
            "Gaedigk Andrea",
            "Caudle Kelly E",
            "Klein Teri E",
            "Johnson Julie A",
            "Shuldiner Alan R"
          ],
          "pmid": "35034351",
          "pmcid": null,
          "doi": "10.1002/cpt.2526",
          "month": 1,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Clopidogrel",
          "id": "RxNorm:32968",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity"
              },
              "drugRecommendation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "CVI non-ACS non-PCI",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "For non-acute coronary syndrome (non-ACS) and non-percutaneous coronary intervention (non-PCI) cardiovascular indications. Non-ACS, non-PCI cardiovascular indications include peripheral arterial disease and stable coronary artery disease following a recent myocardial infarction outside the setting of PCI."
            },
            {
              "implications": {
                "CYP2C19": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity"
              },
              "drugRecommendation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "CVI ACS PCI ",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "For cardiovascular indications of acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI). ACS and/or PCI includes patients undergoing PCI for an ACS or non-ACS (elective) indication."
            },
            {
              "implications": {
                "CYP2C19": "Normal clopidogrel active metabolite formation; normal on-treatment platelet reactivity"
              },
              "drugRecommendation": "If considering clopidogrel, use at standard dose (75 mg/day)",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "NVI",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "For neurovascular indications. Neurovascular disease includes acute ischemic stroke or transient ischemic attack, secondary prevention of stroke, or prevention of thromboembolic events following neurointerventional procedures such as carotid artery stenting and stent-assisted coiling of intracranial aneurysms."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for clopidogrel and CYP2C19",
          "id": "PA166104956",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104956",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "codeine",
      "cpicId": "RxNorm:2670",
      "pharmgkbId": "PA166104970",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104970"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "Mller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, OPRM1, COMT, and Opioids",
          "id": "RxNorm:2670",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced morphine formation"
              },
              "drugRecommendation": "Use codeine label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider a non-tramadol opioid.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for codeine and CYP2D6",
          "id": "PA166104970",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104970",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The genetic variation reduces the conversion of codeine to morphine. This can result in reduced analgesia."
              },
              "drugRecommendation": "For COUGH:\n\u003col\u003e\n\u003cli\u003eNo action required.\u003c/li\u003e\n\u003c/ol\u003e\nFor PAIN:\nIt is not possible to offer adequately substantiated advice for dose adjustment based on the limited available literature for this phenotype.\n\u003col\u003e\n\u003cli\u003eBe alert to a reduced effectiveness.\u003c/li\u003e\n\u003cli\u003eIn the case of inadequate effectiveness: 1. Try a dose increase., 2. If this does not work: choose an alternative.\nDo not select tramadol, as this is also metabolised by CYP2D6. Morphine is not metabolised by CYP2D6. Oxycodone is metabolised by CYP2D6 to a limited extent, but this does not result in differences in analgesia in patients.\u003c/li\u003e\n\u003cli\u003eIf no alternative is selected: advise the patient to report inadequate analgesia.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "desflurane",
      "cpicId": "RxNorm:27340",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:27340",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "desipramine",
      "cpicId": "RxNorm:3247",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:3247",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers. Higher plasma concentrations of active drug will increase the probability of side effects."
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        }
      ]
    },
    {
      "name": "dexlansoprazole",
      "cpicId": "RxNorm:816346",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Proton Pump Inhibitors",
          "id": "RxNorm:816346",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs"
              },
              "drugRecommendation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.\nMonitor for efficacy.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "doxepin",
      "cpicId": "RxNorm:3638",
      "pharmgkbId": "PA166104994",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104994"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:3638",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism of tertiary amines",
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects"
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer",
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a",
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for doxepin and CYP2D6",
          "id": "PA166104994",
          "source": "DPWG",
          "version": "24",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104994",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of doxepin and the active metabolite nordoxepin."
              },
              "drugRecommendation": "Use 80% of the standard dose and monitor the effect and side effects or the plasma concentrations of doxepin and nordoxepin in order to set the maintenance dose. The therapeutic range is 100-250 ng/mL for the sum of doxepin and nordoxepin plasma concentrations. Values higher than 400 ng/mL are considered toxic.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "efavirenz",
      "cpicId": "RxNorm:195085",
      "pharmgkbId": "PA166182846",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/",
        "https://pharmgkb.org/guidelineAnnotation/PA166182846"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy.",
          "authors": [
            "Desta Zeruesenay",
            "Gammal Roseann S",
            "Gong Li",
            "Whirl-Carrillo Michelle",
            "Gaur Aditya H",
            "Sukasem Chonlaphat",
            "Hockings Jennifer",
            "Myers Alan",
            "Swart Marelize",
            "Tyndale Rachel",
            "Masimirembwa Collen",
            "Iwuchukwu Otito F",
            "Chirwa Sanika",
            "Lennox Jeffrey",
            "Gaedigk Andrea",
            "Klein Teri",
            "Haas David W"
          ],
          "pmid": "31006110",
          "pmcid": null,
          "doi": null,
          "month": 4,
          "year": 2019
        }
      ],
      "guidelines": [
        {
          "name": "CYP2B6 and efavirenz",
          "id": "RxNorm:195085",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-efavirenz-based-on-cyp2b6-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2B6": "Normal efavirenz metabolism"
              },
              "drugRecommendation": "Initiate efavirenz with standard dosing (600 mg/day)",
              "classification": "Strong",
              "phenotypes": {
                "CYP2B6": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2B6": "n/a"
              },
              "population": "child \u003e40kg_adult",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2B6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2B6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2B6",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The ENCORE study showed that in treatment-nave patients randomized to initiate efavirenz-based regimens (combined with tenofovir and emtricitabine), 400 mg/day was non-inferior to 600 mg/day regardless of CYP2B6 genotype (PMID 24522178)."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for efavirenz and CYP2B6",
          "id": "PA166182846",
          "source": "DPWG",
          "version": "9",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182846",
          "annotationGroups": [
            {
              "implications": {
                "CYP2B6": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on efavirenz."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for efavirenz in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2B6": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2B6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2B6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2B6",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "eliglustat",
      "cpicId": null,
      "pharmgkbId": "PA166182823",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166182823"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for eliglustat and CYP2D6",
          "id": "PA166182823",
          "source": "DPWG",
          "version": "6",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182823",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "This gene variation reduces the conversion of eliglustat to inactive metabolites. However, in the absence of CYP2D6 and CYP3A inhibitors, this does not result in a clinically significant increased risk of side effects."
              },
              "drugRecommendation": "\u003cul\u003e\n\u003cli\u003eCo-medication with BOTH a MODERATE to STRONG CYP2D6 INHIBITOR AND a MODERATE to STRONG CYP3A INHIBITOR: Eliglustat is contra-indicated.\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eChoose an alternative if possible.\nStrong CYP2D6 inhibitor: for example paroxetine, fluoxetine, quinidine, bupropione. Moderate CYP2D6 inhibitor: for example duloxetine, terbinafine, moclobemide, mirabegron, cinacalcet, dronedarone. Strong CYP3A inhibitor: for example ketoconazole, clarithromycin, itraconazole, cobicistat, indinavir, lopinavir, ritonavir, saquinavir, telaprevir, tipranavir, posaconazole, voriconazole, telithromycin, conivaptan, boceprevir. Moderate CYP3A inhibitor: for example erythromycin, ciprofloxacin, fluconazole, diltiazem, verapamil, aprepitant, atazanavir, darunavir, fosamprenavir, imatinib, cimetidine.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eCo-medication with a STRONG CYP2D6 INHIBITOR (e.g. paroxetine, fluoxetine, quinidine, bupropione):\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eUse a dose of 84mg eliglustat 1x daily.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eCo-medication with a MODERATE CYP2D6 INHIBITOR (for example duloxetine, terbinafine, moclobemide, mirabegron, cinacalcet, dronedarone):\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eConsider a dose of 84mg eliglustat 1x daily.\u003c/li\u003e\n\u003cli\u003eBe alert to side effects.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eCo-medication with a STRONG CYP3A INHIBITOR (for example ketoconazole, clarithromycin, itraconazole, cobicistat, indinavir, lopinavir, ritonavir, saquinavir, telaprevir, tipranavir, posaconazole, voriconazole, telithromycin, conivaptan, boceprevir):\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eChoose an alternative if possible.\u003c/li\u003e\n\u003cli\u003eIf an alternative is not an option: consider a dose of 84 mg eliglustat 1x daily and be alert to side effects.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eCo-medication with a MODERATE CYP3A INHIBITOR (for example erythromycin, ciprofloxacin, fluconazole, diltiazem, verapamil, aprepitant, atazanavir, darunavir, fosamprenavir, imatinib, cimetidine):\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eChoose an alternative.\u003c/li\u003e\n\u003cli\u003eIf an alternative is not an option: consider a dose of 84mg eliglustat 1x daily and be alert to side effects.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eCo-medication with a STRONG CYP3A INDUCER (for example rifampicin, carbamazepine, phenobarbital, phenytoin, rifabutine, hypericum): Eliglustat is not recommended. The plasma concentration may decrease so sharply that a therapeutic effect cannot be achieved.\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eChoose an alternative if possible.\u003c/li\u003e\n\u003c/ol\u003e\n\u003cul\u003e\n\u003cli\u003eNO co-medication with a moderate or strong CYP2D6 or CYP3A inhibitor or strong CYP3A inducer:\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003eUse the standard dose of 84mg 2x daily.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "enflurane",
      "cpicId": "RxNorm:3920",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:3920",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "escitalopram",
      "cpicId": "RxNorm:321988",
      "pharmgkbId": "PA166104975",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104975"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Mller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrin",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors",
          "id": "RxNorm:321988",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for escitalopram and CYP2C19",
          "id": "PA166104975",
          "source": "DPWG",
          "version": "30",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104975",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "flecainide",
      "cpicId": null,
      "pharmgkbId": "PA166104969",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104969"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for flecainide and CYP2D6",
          "id": "PA166104969",
          "source": "DPWG",
          "version": "26",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104969",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The genetic variation reduces conversion of flecainide to inactive metabolites. This may increase the risk of side effects."
              },
              "drugRecommendation": "\u003col\u003e\n\u003cli\u003eIndications other than diagnosis of Brugada syndrome: reduce the dose to 75% of the standard dose and record an ECG and monitor the plasma concentration.2.Provocation test for diagnosis of Brugada syndrome:No action required.At a dose of 2.0 mg/kg body weight to a maximum of 150 mg, the response is better for patients with alleles that result in reduced activity.All 5 patients with these alleles and 20% of the patients with two fully active alleles exhibited a response within 30 minutes.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "flucloxacillin",
      "cpicId": null,
      "pharmgkbId": "PA166182810",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166182810"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for flucloxacillin and HLA-B",
          "id": "PA166182810",
          "source": "DPWG",
          "version": "6",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182810",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "HLA-B*57:01-positive patients have an 80-fold elevated risk of flucloxacillin-induced liver injury. However, the incidence is low (1-2 per 1000 individuals)."
              },
              "drugRecommendation": "\u003col\u003e\n\u003cli\u003eRegularly monitor the patients liver function\u003c/li\u003e\n\u003cli\u003eChoose an alternative if liver enzymes and/or bilirubin levels are elevated\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "flucytosine",
      "cpicId": null,
      "pharmgkbId": "PA166222801",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166222801"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for flucytosine and DPYD",
          "id": "PA166222801",
          "source": "DPWG",
          "version": "5",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166222801",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "The guideline does not provide a description of the impact of a DPYD activity score of 2 on flucytosine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for flucytosine in patients with a DPYD activity score of 2.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {
                "DPYD": "2"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "fluorouracil",
      "cpicId": "RxNorm:4492",
      "pharmgkbId": "PA166104939",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104939"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing",
          "authors": [
            "Caudle Kelly E",
            "Thorn Caroline F",
            "Klein Teri E",
            "Swen Jesse J",
            "McLeod Howard L",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "23988873",
          "pmcid": "PMC3831181",
          "doi": "10.1038/clpt.2013.172",
          "month": 8,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
          "authors": [
            "Amstutz Ursula",
            "Henricks Linda M",
            "Offer Steven M",
            "Barbarino Julia",
            "Schellens Jan H M",
            "Swen Jesse J",
            "Klein Teri E",
            "McLeod Howard L",
            "Caudle Kelly E",
            "Diasio Robert B",
            "Schwab Matthias"
          ],
          "pmid": "29152729",
          "pmcid": "PMC5760397",
          "doi": "10.1002/cpt.911",
          "month": 11,
          "year": 2017
        }
      ],
      "guidelines": [
        {
          "name": "DPYD and Fluoropyrimidines",
          "id": "RxNorm:4492",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-fluoropyrimidines-and-dpyd/",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "Normal DPD activity and \"normal\" risk for fluoropyrimidine toxicity"
              },
              "drugRecommendation": "Based on genotype, there is no indication to change dose or therapy. Use label-recommended dosage and administration.",
              "classification": "Strong",
              "phenotypes": {
                "DPYD": "Normal Metabolizer"
              },
              "activityScore": {
                "DPYD": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for fluorouracil and DPYD",
          "id": "PA166104939",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104939",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "The guideline does not provide a description of the impact of a DPYD activity score of 2 on fluorouracil."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for fluorouracil in patients with a DPYD activity score of 2.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {
                "DPYD": "2"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "flurbiprofen",
      "cpicId": "RxNorm:4502",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:4502",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "fluvastatin",
      "cpicId": "RxNorm:41127",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:41127",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal exposure.",
                "SLCO1B1": "Typical myopathy risk and statin exposure."
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses of fluvastatin based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer",
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        }
      ]
    },
    {
      "name": "fluvoxamine",
      "cpicId": "RxNorm:42355",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Mller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrin",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors",
          "id": "RxNorm:42355",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced metabolism when compared to normal metabolizers. Higher plasma concentrations may increase the probability of side effects."
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "fosphenytoin",
      "cpicId": "RxNorm:72236",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing",
          "authors": [
            "Caudle Kelly E",
            "Rettie Allan E",
            "Whirl-Carrillo Michelle",
            "Smith Lisa H",
            "Mintzer Scott E",
            "Lee Ming Ta Michael",
            "Klein Teri E",
            "Callaghan J Thomas"
          ],
          "pmid": "25099164",
          "pmcid": "PMC4206662",
          "doi": "10.1038/clpt.2014.159",
          "month": 8,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.",
          "authors": [
            "Karnes Jason H",
            "Rettie Allan E",
            "Somogyi Andrew A",
            "Huddart Rachel",
            "Fohner Alison E",
            "Formea Christine M",
            "Lee Ming Ta Michael",
            "Llerena Adrian",
            "Whirl-Carrillo Michelle",
            "Klein Teri E",
            "Phillips Elizabeth J",
            "Mintzer Scott",
            "Gaedigk Andrea",
            "Caudle Kelly E",
            "Callaghan John T"
          ],
          "pmid": "32779747",
          "pmcid": null,
          "doi": null,
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9, HLA-B and Phenytoin",
          "id": "RxNorm:72236",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal phenytoin metabolism",
                "HLA-B": "Increased risk of phenytoin-induced SJS/TEN"
              },
              "drugRecommendation": "If patient is phenytoin-naive, do not use phenytoin/fosphenytoin. Avoid carbamazepine and oxcarbazepine.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "PHT naive",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Other aromatic anticonvulsants, including eslicarbazepine, lamotrigine, and phenobarbital, have weaker evidence linking SJS/TEN with the HLA-B*15:02 allele; however, caution should still be used in choosing an alternative agent."
            },
            {
              "implications": {
                "CYP2C9": "Normal phenytoin metabolism",
                "HLA-B": "Increased risk of phenytoin-induced SJS/TEN"
              },
              "drugRecommendation": "If the patient has previously used phenytoin continuously for longer than three months without incidence of cutaneous adverse reactions, cautiously consider use of phenytoin in the future. The latency period for drug-induced SJS/TEN is short with continuous dosing and adherence to therapy (4-28 days), and cases usually occur within three months of dosing.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "PHT use \u003e3mos",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Previous tolerance of phenytoin is not indicative of tolerance to other aromatic anticonvulsants."
            }
          ]
        }
      ]
    },
    {
      "name": "gentamicin",
      "cpicId": "ATC:D06AX07",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "ATC:D06AX07",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "haloperidol",
      "cpicId": null,
      "pharmgkbId": "PA166104988",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104988"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for haloperidol and CYP2D6",
          "id": "PA166104988",
          "source": "DPWG",
          "version": "26",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104988",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The genetic variation results in a higher plasma concentration, but the effect is small and no clinically significant effects were found."
              },
              "drugRecommendation": "NO action is required for this gene-drug interaction.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "halothane",
      "cpicId": "RxNorm:5095",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:5095",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "hormonal contraceptives for systemic use",
      "cpicId": null,
      "pharmgkbId": "PA166104955",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104955"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for hormonal contraceptives for systemic use and F5",
          "id": "PA166104955",
          "source": "DPWG",
          "version": "25",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104955",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "hydrocodone",
      "cpicId": "RxNorm:5489",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "Mller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, OPRM1, COMT, and Opioids",
          "id": "RxNorm:5489",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Minimal evidence for pharmacokinetic or clinical effect."
              },
              "drugRecommendation": "Use hydrocodone label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine or non-tramadol opioid.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "ibuprofen",
      "cpicId": "RxNorm:5640",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:5640",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "imipramine",
      "cpicId": "RxNorm:5691",
      "pharmgkbId": "PA166104972",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104954",
        "https://pharmgkb.org/guidelineAnnotation/PA166104972"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:5691",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism of tertiary amines",
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects"
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer",
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a",
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for imipramine and CYP2C19",
          "id": "PA166104954",
          "source": "DPWG",
          "version": "27",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104954",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for imipramine and CYP2D6",
          "id": "PA166104972",
          "source": "DPWG",
          "version": "27",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104972",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects may be increased, because the gene variation leads to increased plasma concentrations of imipramine and desipramine."
              },
              "drugRecommendation": "Use 70% of the standard dose and monitor the effect and side effects or the plasma concentrations of imipramine and desipramine in order to set the maintenance dose. The therapeutic range is 150-300 ng/mL for the sum of the imipramine and desipramine plasma concentrations. Values exceeding 500 ng/mL are considered toxic.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "irinotecan",
      "cpicId": null,
      "pharmgkbId": "PA166104951",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104951"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for irinotecan and UGT1A1",
          "id": "PA166104951",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104951",
          "annotationGroups": [
            {
              "implications": {
                "UGT1A1": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on irinotecan."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for irinotecan in normal metabolizers",
              "classification": "N/A",
              "phenotypes": {
                "UGT1A1": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "UGT1A1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "UGT1A1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "UGT1A1",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "isoflurane",
      "cpicId": "RxNorm:6026",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:6026",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "ivacaftor",
      "cpicId": "RxNorm:1243041",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype",
          "authors": [
            "Clancy John P",
            "Johnson Samuel G",
            "Yee Sook Wah",
            "McDonagh Ellen M",
            "Caudle Kelly E",
            "Klein Teri E",
            "Cannavo Matthew",
            "Giacomini Kathleen M"
          ],
          "pmid": "24598717",
          "pmcid": "PMC4026598",
          "doi": "10.1038/clpt.2014.54",
          "month": 3,
          "year": 2014
        }
      ],
      "guidelines": [
        {
          "name": "CFTR and Ivacaftor",
          "id": "RxNorm:1243041",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-ivacaftor-and-cftr/",
          "annotationGroups": [
            {
              "implications": {
                "CFTR": "An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor."
              },
              "drugRecommendation": "Ivacaftor is not recommended",
              "classification": "Moderate",
              "phenotypes": {
                "CFTR": "ivacaftor non-responsive in CF patients"
              },
              "activityScore": {
                "CFTR": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CFTR",
                        "name": "ivacaftor non-responsive CFTR sequence",
                        "function": "ivacaftor non-responsive",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CFTR",
                        "name": "ivacaftor non-responsive CFTR sequence",
                        "function": "ivacaftor non-responsive",
                        "reference": true
                      },
                      "gene": "CFTR",
                      "phenotypes": [
                        "ivacaftor non-responsive in CF patients"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "ivacaftor non-responsive in CF patients"
                      ],
                      "label": "No CPIC variants found",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "kanamycin",
      "cpicId": "RxNorm:6099",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:6099",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "lamotrigine",
      "cpicId": null,
      "pharmgkbId": "PA166265341",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166265341"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for lamotrigine and HLA-B",
          "id": "PA166265341",
          "source": "DPWG",
          "version": "3",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265341",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "The life-threatening cutaneous side effect Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) occurs more often in patients with this genetic variation. Based on the estimated risk for all patients and the increase by a factor 3.6 for patients with this genetic variation, the risk of lamotrigine-induced SJS/TEN in patients with HLA-B*1502 is estimated at 0.4%."
              },
              "drugRecommendation": "\u003cul\u003e\n\u003cli\u003eCarefully weigh the risk of SJS/TEN against the benefits.\u003c/li\u003e\n\u003cli\u003eAvoid lamotrigine if an alternative is available.\n\u003cul\u003e\n\u003cli\u003eCarbamazepine carries a much higher risk of SJS/TEN in these patients and is therefore not an alternative.\u003c/li\u003e\n\u003cli\u003eA similar risk has been reported for phenytoin as for lamotrigine.\u003c/li\u003e\n\u003cli\u003eThe same applies to oxcarbazepine, but the most severe forms (SJS/TEN overlap and TEN) have not been observed with oxcarbazepine.\u003c/li\u003e\n\u003c/ul\u003e\n\u003c/li\u003e\n\u003cli\u003eIf it is not possible to avoid these products, advise the patient to report any rash immediately.\u003c/li\u003e\n\u003c/ul\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "lansoprazole",
      "cpicId": "RxNorm:17128",
      "pharmgkbId": "PA166104987",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104987"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Proton Pump Inhibitors",
          "id": "RxNorm:17128",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs"
              },
              "drugRecommendation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.\nMonitor for efficacy.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for lansoprazole and CYP2C19",
          "id": "PA166104987",
          "source": "DPWG",
          "version": "25",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104987",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "lornoxicam",
      "cpicId": "RxNorm:20890",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:20890",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "lovastatin",
      "cpicId": "RxNorm:6472",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:6472",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "population general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        }
      ]
    },
    {
      "name": "meloxicam",
      "cpicId": "RxNorm:41493",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:41493",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "mercaptopurine",
      "cpicId": "RxNorm:103",
      "pharmgkbId": "PA166104952",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
        "https://pharmgkb.org/guidelineAnnotation/PA166184613",
        "https://pharmgkb.org/guidelineAnnotation/PA166104952"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "TPMT, NUDT15 and Thiopurines",
          "id": "RxNorm:103",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
                "TPMT": "Lower concentrations of TGN metabolites, higher MeTIMP, this is the normal pattern. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression."
              },
              "drugRecommendation": "Start with normal starting dose (e.g., 75 mg/m2/day or 1.5 mg/kg/day) and adjust doses of mercaptopurine (and of any other myelosuppressive therapy) without any special emphasis on mercaptopurine compared to other agents. Allow at least 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 16401827, 11302950).",
              "classification": "Strong",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer",
                "TPMT": "Normal Metabolizer"
              },
              "activityScore": {
                "NUDT15": "n/a",
                "TPMT": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "TPMT",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for mercaptopurine and NUDT15",
          "id": "PA166184613",
          "source": "DPWG",
          "version": "7",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166184613",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for mercaptopurine in normal metabolizers",
              "classification": "N/A",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for mercaptopurine and TPMT",
          "id": "PA166104952",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104952",
          "annotationGroups": [
            {
              "implications": {
                "TPMT": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on mercaptopurine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for mercaptopurine in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "TPMT": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "TPMT",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "methoxyflurane",
      "cpicId": "RxNorm:6857",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:6857",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "metoprolol",
      "cpicId": null,
      "pharmgkbId": "PA166104995",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104995"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for metoprolol and CYP2D6",
          "id": "PA166104995",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104995",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The gene variation reduces the conversion of metoprolol to inactive metabolites. However, the clinical consequences are limited mainly to the occurrence of asymptomatic bradycardia."
              },
              "drugRecommendation": "If a GRADUAL REDUCTION in HEART RATE is desired, or in the event of SYMPTOMATIC BRADYCARDIA: 1. use smaller steps in dose titration and/or prescribe no more than 50% of the standard dose. OTHER CASES: 1. no action required",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "nortriptyline",
      "cpicId": "RxNorm:7531",
      "pharmgkbId": "PA166104961",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104961"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:7531",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced metabolism of tricyclic antidepressants to less active compounds compared to normal metabolizers. Higher plasma concentrations of active drug will increase the probability of side effects."
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Titrate dose to observed clinical response with symptom improvement and minimal (if any) side effects. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of tricyclic antidepressants for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for nortriptyline and CYP2D6",
          "id": "PA166104961",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104961",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects may be increased, because the gene variation leads to an increased plasma concentration of nortriptyline."
              },
              "drugRecommendation": "Use 60% of the standard dose and monitor the effect and side effects or the plasma concentration of nortriptyline in order to set the maintenance dose.\nThe therapeutic range of nortriptyline is 50-150 ng/mL. Values exceeding 250 ng/mL are considered toxic.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "omeprazole",
      "cpicId": "RxNorm:7646",
      "pharmgkbId": "PA166104957",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104957"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Proton Pump Inhibitors",
          "id": "RxNorm:7646",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs"
              },
              "drugRecommendation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.\nMonitor for efficacy.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for omeprazole and CYP2C19",
          "id": "PA166104957",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104957",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "ondansetron",
      "cpicId": "RxNorm:26225",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron",
          "authors": [
            "Bell Gillian C",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Gordon Ronald J",
            "Hikino Keiko",
            "Prows Cynthia A",
            "Gaedigk Andrea",
            "Agundez Jose A G",
            "Sadhasivam Senthilkumar",
            "Klein Teri E",
            "Schwab Matthias"
          ],
          "pmid": "28002639",
          "pmcid": "PMC5479760",
          "doi": "10.1002/cpt.598",
          "month": 12,
          "year": 2016
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6 and Ondansetron and Tropisetron",
          "id": "RxNorm:26225",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Very limited data available for CYP2D6 intermediate metabolizers"
              },
              "drugRecommendation": "Insufficient evidence demonstrating clinical impact based on CYP2D6 genotype. Initiate therapy with recommended starting dose.",
              "classification": "No Recommendation",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Drug-drug interactions and other patient characteristics (e.g., age, renal function, and liver function) should be considered when selecting alternative therapy."
            }
          ]
        }
      ]
    },
    {
      "name": "oxcarbazepine",
      "cpicId": "RxNorm:32624",
      "pharmgkbId": "PA166265201",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/",
        "https://pharmgkb.org/guidelineAnnotation/PA166265201"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing",
          "authors": [
            "Leckband Susan G",
            "Kelsoe John R",
            "Dunnenberger H Mark",
            "George Alfred L",
            "Tran Eric",
            "Berger Reisel",
            "Mller Daniel J",
            "Whirl-Carrillo Michelle",
            "Caudle Kelly E",
            "Pirmohamed Munir"
          ],
          "pmid": "23695185",
          "pmcid": "PMC3748365",
          "doi": "10.1038/clpt.2013.103",
          "month": 5,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.",
          "authors": [
            "Phillips Elizabeth J",
            "Sukasem Chonlaphat",
            "Whirl-Carrillo Michelle",
            "Mller Daniel J",
            "Dunnenberger Henry M",
            "Chantratita Wasun",
            "Goldspiel Barry",
            "Chen Yuan-Tsong",
            "Carleton Bruce C",
            "George Alfred L",
            "Mushiroda Taisei",
            "Klein Teri",
            "Gammal Roseann S",
            "Pirmohamed Munir"
          ],
          "pmid": "29392710",
          "pmcid": "PMC5847474",
          "doi": "10.1002/cpt.1004",
          "month": 4,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "HLA-A, HLA-B and Carbamazepine and Oxcarbazepine",
          "id": "RxNorm:32624",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-carbamazepine-and-hla-b/",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "Greater risk of oxcarbazepine-induced SJS/TEN"
              },
              "drugRecommendation": "If patient is oxcarbazepine-nave, do not use oxcarbazepine.",
              "classification": "Strong",
              "phenotypes": {},
              "activityScore": {},
              "population": "OXC naive",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Other aromatic anticonvulsants have weaker evidence linking SJS/TEN with the HLA-B*15:02 allele; however, caution should still be used in choosing an alternative agent. Aromatic anticonvulsants include carbamazepine, oxcarbazepine, eslicarbazepine, lamotrigine, phenytoin, fosphenytoin, and phenobarbital."
            },
            {
              "implications": {
                "HLA-B": "Greater risk of oxcarbazepine-induced SJS/TEN"
              },
              "drugRecommendation": "The latency period for drug-induced SJS/TEN is short with continuous dosing and adherence to therapy (~4-28 days), and cases usually occur within three months of dosing; therefore, if the patient has previously used oxcarbazepine consistently for longer than three months without incidence of cutaneous adverse reactions, cautiously consider use of oxcarbazepine in the future.",
              "classification": "Optional",
              "phenotypes": {},
              "activityScore": {
                "HLA-B": "n/a"
              },
              "population": "OXC use \u003e3 mos",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Previous tolerance of oxcarbazepine is not indicative of tolerance to other aromatic anticonvulsants. Aromatic anticonvulsants include carbamazepine, oxcarbazepine, eslicarbazepine, lamotrigine, phenytoin, fosphenytoin, and phenobarbital."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for oxcarbazepine and HLA-B",
          "id": "PA166265201",
          "source": "DPWG",
          "version": "3",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265201",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "Stevens-Johnson syndrome, the severe cutaneous side effect that can potentially result in permanent damage, occurs more often in patients with this genetic variation. The calculated risk of oxcarbazepine-induced SJS in patients with HLA-B*1502 is 0.73%."
              },
              "drugRecommendation": "\u003cul\u003e\n\u003cli\u003eCarefully weigh the risk of SJS against the benefits.\u003c/li\u003e\n\u003cli\u003eAvoid oxcarbazepine if an alternative is available.\n\u003cul\u003e\n\u003cli\u003eCarbamazepine carries a 10-fold higher risk of SJS/TEN in these patients and is therefore not an alternative.\u003c/li\u003e\n\u003cli\u003eIn these patients, phenytoin and lamotrigine carry a similar risk of SJS/TEN as oxcarbazepine, but more severe forms of SJS/TEN (SJS/TEN overlap and TEN) are also\nobserved with these medicines. Therefore, they are also not suitable as alternatives.\u003c/li\u003e\n\u003c/ul\u003e\n\u003c/li\u003e\n\u003cli\u003eIf it is not possible to avoid oxcarbazepine, advise the patient to report any rash immediately\u003c/li\u003e\n\u003c/ul\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "pantoprazole",
      "cpicId": "RxNorm:40790",
      "pharmgkbId": "PA166104958",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104958"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.",
          "authors": [
            "Lima John J",
            "Thomas Cameron D",
            "Barbarino Julia",
            "Desta Zeruesenay",
            "Van Driest Sara L",
            "El Rouby Nihal",
            "Johnson Julie A",
            "Cavallari Larisa H",
            "Shakhnovich Valentina",
            "Thacker David L",
            "Scott Stuart A",
            "Schwab Matthias",
            "Uppugunduri Chakradhara Rao S",
            "Formea Christine M",
            "Franciosi James P",
            "Sangkuhl Katrin",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Gammal Roseann S",
            "Furuta Takahisa"
          ],
          "pmid": "32770672",
          "pmcid": null,
          "doi": "10.1002/cpt.2015",
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Proton Pump Inhibitors",
          "id": "RxNorm:40790",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal PPI metabolism; may be at increased risk of therapeutic failure compared to CYP2C19 IMs and PMs"
              },
              "drugRecommendation": "Initiate standard starting daily dose. Consider increasing dose by 50-100% for the treatment of H. pylori infection and erosive esophagitis. Daily dose may be given in divided doses.\nMonitor for efficacy.",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for pantoprazole and CYP2C19",
          "id": "PA166104958",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104958",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "paromomycin",
      "cpicId": "RxNorm:7934",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:7934",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "paroxetine",
      "cpicId": "RxNorm:32937",
      "pharmgkbId": "PA166104976",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104976"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Mller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrin",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors",
          "id": "RxNorm:32937",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced metabolism when compared to normal metabolizers. Higher plasma concentrations may increase the probability of side effects."
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose",
              "classification": "Moderate",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for paroxetine and CYP2D6",
          "id": "PA166104976",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104976",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
              },
              "drugRecommendation": "NO action is needed for this gene-drug interaction.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "peginterferon alfa-2a",
      "cpicId": "RxNorm:120608",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens",
          "authors": [
            "Muir Andrew J",
            "Gong Li",
            "Johnson Samuel G",
            "Michael Lee Ming Ta",
            "Williams Marc S",
            "Klein Teri E",
            "Caudle Kelly E",
            "Nelson David R"
          ],
          "pmid": "24096968",
          "pmcid": "PMC3904555",
          "doi": "10.1038/clpt.2013.203",
          "month": 10,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "IFNL3 and Peginterferon-alpha-based Regimens",
          "id": "RxNorm:120608",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "peginterferon alfa-2b",
      "cpicId": "RxNorm:253453",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens",
          "authors": [
            "Muir Andrew J",
            "Gong Li",
            "Johnson Samuel G",
            "Michael Lee Ming Ta",
            "Williams Marc S",
            "Klein Teri E",
            "Caudle Kelly E",
            "Nelson David R"
          ],
          "pmid": "24096968",
          "pmcid": "PMC3904555",
          "doi": "10.1038/clpt.2013.203",
          "month": 10,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "IFNL3 and Peginterferon-alpha-based Regimens",
          "id": "RxNorm:253453",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-peg-interferon-alpha-based-regimens-and-ifnl3/",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "phenprocoumon",
      "cpicId": null,
      "pharmgkbId": "PA166104940",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104940"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for phenprocoumon and VKORC1",
          "id": "PA166104940",
          "source": "DPWG",
          "version": "32",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104940",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "phenytoin",
      "cpicId": "RxNorm:8183",
      "pharmgkbId": "PA166264881",
      "messages": [
        {
          "rule_name": "Phenytoin_HLA-B warning",
          "version": "1",
          "matches": {
            "gene": "",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": [
              "phenytoin"
            ]
          },
          "exception_type": "note",
          "message": "The displayed recommendation for CYP2C9 and phenytoin is ONLY valid for non-carriers of the HLA-B*15:02 high-risk allele. PharmCAT does not interpret HLA carrier status. Phenytoin is contraindicated in individuals with the HLA-B*15:02 variant allele (\"HLA-B*15:02-positive\") due to significantly increased risk of phenytoin-induced cutaneous adverse reactions of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). In HLA-B*15:02 carriers, carbamazepine should not be used as an alternative. Alternative medications such as oxcarbazepine, eslicarbazepine acetate, and lamotrigine have some evidence linking SJS/TEN with the HLA-B*15:02 allele, and thus caution should be used in choosing alternatives to phenytoin."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104984",
        "https://pharmgkb.org/guidelineAnnotation/PA166264881"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing",
          "authors": [
            "Caudle Kelly E",
            "Rettie Allan E",
            "Whirl-Carrillo Michelle",
            "Smith Lisa H",
            "Mintzer Scott E",
            "Lee Ming Ta Michael",
            "Klein Teri E",
            "Callaghan J Thomas"
          ],
          "pmid": "25099164",
          "pmcid": "PMC4206662",
          "doi": "10.1038/clpt.2014.159",
          "month": 8,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.",
          "authors": [
            "Karnes Jason H",
            "Rettie Allan E",
            "Somogyi Andrew A",
            "Huddart Rachel",
            "Fohner Alison E",
            "Formea Christine M",
            "Lee Ming Ta Michael",
            "Llerena Adrian",
            "Whirl-Carrillo Michelle",
            "Klein Teri E",
            "Phillips Elizabeth J",
            "Mintzer Scott",
            "Gaedigk Andrea",
            "Caudle Kelly E",
            "Callaghan John T"
          ],
          "pmid": "32779747",
          "pmcid": null,
          "doi": null,
          "month": 8,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9, HLA-B and Phenytoin",
          "id": "RxNorm:8183",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-phenytoin-and-cyp2c9-and-hla-b/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal phenytoin metabolism",
                "HLA-B": "Increased risk of phenytoin-induced SJS/TEN"
              },
              "drugRecommendation": "If patient is phenytoin-naive, do not use phenytoin/fosphenytoin. Avoid carbamazepine and oxcarbazepine.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "PHT naive",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Other aromatic anticonvulsants, including eslicarbazepine, lamotrigine, and phenobarbital, have weaker evidence linking SJS/TEN with the HLA-B*15:02 allele; however, caution should still be used in choosing an alternative agent."
            },
            {
              "implications": {
                "CYP2C9": "Normal phenytoin metabolism",
                "HLA-B": "Increased risk of phenytoin-induced SJS/TEN"
              },
              "drugRecommendation": "If the patient has previously used phenytoin continuously for longer than three months without incidence of cutaneous adverse reactions, cautiously consider use of phenytoin in the future. The latency period for drug-induced SJS/TEN is short with continuous dosing and adherence to therapy (4-28 days), and cases usually occur within three months of dosing.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "PHT use \u003e3mos",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Previous tolerance of phenytoin is not indicative of tolerance to other aromatic anticonvulsants."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for phenytoin and CYP2C9",
          "id": "PA166104984",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104984",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on phenytoin."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for phenytoin in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for phenytoin and HLA-B",
          "id": "PA166264881",
          "source": "DPWG",
          "version": "4",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166264881",
          "annotationGroups": [
            {
              "implications": {
                "HLA-B": "The life-threatening cutaneous side effect Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) occurs more frequently in patients with this genetic variation. The calculated risk of phenytoin-induced SJS/TEN in patients with HLA-B*1502 is 0.65%."
              },
              "drugRecommendation": "\u003cul\u003e\n\u003cli\u003eCarefully weigh the risk of SJS/TEN against the benefits\u003c/li\u003e\n\u003cli\u003eAvoid phenytoin if an alternative is possible\n\u003cul\u003e\n\u003cli\u003eCarbamazepine carries a 10-fold higher risk of SJS/TEN for these patients and is therefore not an alternative.\u003c/li\u003e\n\u003cli\u003eA comparable risk has been reported for lamotrigine as for phenytoin. The same applies for oxcarbazepine, but the most severe forms (SJS/TEN overlap and TEN) are not observed with oxcarbazepine.\u003c/li\u003e\n\u003c/ul\u003e\n\u003c/li\u003e\n\u003cli\u003eif it is not possible to avoid this medication, then advise the patient to report any skin rash immediately\u003c/li\u003e\n\u003c/ul\u003e",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "HLA-B",
                        "name": "*15:02",
                        "function": null,
                        "reference": false
                      },
                      "allele2": {
                        "gene": "HLA-B",
                        "name": "*57:01",
                        "function": null,
                        "reference": false
                      },
                      "gene": "HLA-B",
                      "phenotypes": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "*15:02 positive",
                        "*57:01 positive",
                        "*58:01 negative"
                      ],
                      "label": "*15:02/*57:01",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "pimozide",
      "cpicId": null,
      "pharmgkbId": "PA166182819",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166182819"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for pimozide and CYP2D6",
          "id": "PA166182819",
          "source": "DPWG",
          "version": "10",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182819",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of QT-prolongation  and thereby also the risk of torsade de points  is theoretically increased, because the genetic variation results in an increase in the plasma concentration of pimozide. The elevated plasma concentration and associated theoretical increased risk of QT elongation can be negated by following the dose recommendations provided below."
              },
              "drugRecommendation": "Use no more than the following doses (80% of the standard maximum dose):\n12 years and older: 16 mg/day\nyounger than 12 years: 0.08 mg/kg per day to a maximum of 3 mg/day",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "piroxicam",
      "cpicId": "RxNorm:8356",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:8356",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "pitavastatin",
      "cpicId": "RxNorm:861634",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:861634",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "population general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        }
      ]
    },
    {
      "name": "plazomicin",
      "cpicId": "RxNorm:2049549",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:2049549",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "pravastatin",
      "cpicId": "RxNorm:42463",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:42463",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "population general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        }
      ]
    },
    {
      "name": "propafenone",
      "cpicId": null,
      "pharmgkbId": "PA166104962",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104962"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for propafenone and CYP2D6",
          "id": "PA166104962",
          "source": "DPWG",
          "version": "26",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104962",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Genetic variation increases the sum of the plasma concentrations of propafenone and the active metabolite 5-hydroxypropafenone. This may increase the risk of side effects."
              },
              "drugRecommendation": "It is not possible to offer adequately substantiated recommendations for dose adjustment based on the literature.\n\u003col\u003e\n\u003cli\u003eEither guide the dose by therapeutic drug monitoring, perform an ECG and be alert to side effects\u003c/li\u003e\n\u003cli\u003eOr choose an alternative. Antiarrhythmic drugs that are hardly if at all metabolised by CYP2D6 include, for example, sotalol, disopyramide, quinidine and amiodarone.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "quetiapine",
      "cpicId": null,
      "pharmgkbId": "PA166265421",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP3A4 alleles is missing which may change the matched genotype. See the gene section for CYP3A4 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166265421"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for quetiapine and CYP3A4",
          "id": "PA166265421",
          "source": "DPWG",
          "version": "7",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166265421",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "rasburicase",
      "cpicId": "RxNorm:283821",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-rasburicase-and-g6pd/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the context of G6PD Deficiency Genotype",
          "authors": [
            "Relling Mary V",
            "McDonagh Ellen M",
            "Chang Tamara",
            "Caudle Kelly E",
            "McLeod Howard L",
            "Haidar Cyrine E",
            "Klein Teri",
            "Luzzatto Lucio"
          ],
          "pmid": "24787449",
          "pmcid": "PMC4111801",
          "doi": "10.1038/clpt.2014.97",
          "month": 5,
          "year": 2014
        }
      ],
      "guidelines": [
        {
          "name": "G6PD and Rasburicase",
          "id": "RxNorm:283821",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-rasburicase-and-g6pd/",
          "annotationGroups": [
            {
              "implications": {
                "G6PD": "Low or reduced risk of hemolytic anemia"
              },
              "drugRecommendation": "No reason to withhold rasburicase based on G6PD status.",
              "classification": "Strong",
              "phenotypes": {
                "G6PD": "Normal"
              },
              "activityScore": {
                "G6PD": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "G6PD",
                        "name": "B (wildtype)",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "G6PD",
                        "name": "B (wildtype)",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "G6PD",
                      "phenotypes": [
                        "Normal"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal"
                      ],
                      "label": "B (wildtype)/B (wildtype)",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "A negative or inconclusive genetic test cannot be assumed to indicate normal G6PD phenotype; an enzyme actiity test is needed to assign G6PD phenotype in such cases."
            }
          ]
        }
      ]
    },
    {
      "name": "risperidone",
      "cpicId": null,
      "pharmgkbId": "PA166104943",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104943"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for risperidone and CYP2D6",
          "id": "PA166104943",
          "source": "DPWG",
          "version": "30",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104943",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "There is little evidence to support an increase in side effects caused by the gene variation. The gene variation may lead to a decrease in the required maintenance dose. However, as the effect on the dose is smaller than that of the normal biological variation, action is not useful."
              },
              "drugRecommendation": "NO action is needed for this gene-drug interaction.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "rosuvastatin",
      "cpicId": "RxNorm:301542",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define ABCG2 alleles is missing which may change the matched genotype. See the gene section for ABCG2 for more information."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:301542",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "ABCG2": "n/a",
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Based on SLCO1B1 status, prescribe desired starting dose and adjust doses based on disease-specific guidelines. ABCG2 genotype result is not available.",
              "classification": "Strong",
              "phenotypes": {
                "ABCG2": "No Result",
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "ABCG2",
                        "name": "Unknown",
                        "function": "Unassigned function",
                        "reference": false
                      },
                      "allele2": {
                        "gene": "ABCG2",
                        "name": "Unknown",
                        "function": "Unassigned function",
                        "reference": false
                      },
                      "gene": "ABCG2",
                      "phenotypes": [
                        "No Result"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "No Result"
                      ],
                      "label": "Unknown/Unknown",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        }
      ]
    },
    {
      "name": "sertraline",
      "cpicId": "RxNorm:36437",
      "pharmgkbId": "PA166104980",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104980"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
          "authors": [
            "Hicks J Kevin",
            "Bishop Jeffrey R",
            "Sangkuhl Katrin",
            "Mller Daniel J",
            "Ji Yuan",
            "Leckband Susan G",
            "Leeder J Steven",
            "Graham Rebecca L",
            "Chiulli Dana L",
            "LLerena Adrin",
            "Skaar Todd C",
            "Scott Stuart A",
            "Stingl Julia C",
            "Klein Teri E",
            "Caudle Kelly E",
            "Gaedigk Andrea"
          ],
          "pmid": "25974703",
          "pmcid": "PMC4512908",
          "doi": "10.1002/cpt.147",
          "month": 5,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Selective Serotonin Reuptake Inhibitors",
          "id": "RxNorm:36437",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for sertraline and CYP2C19",
          "id": "PA166104980",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104980",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "sevoflurane",
      "cpicId": "RxNorm:36453",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:36453",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "simvastatin",
      "cpicId": "RxNorm:36567",
      "pharmgkbId": "PA166182844",
      "messages": [
        {
          "rule_name": "SLCO1B1-simvastatin text",
          "version": "1",
          "matches": {
            "gene": "",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": [
              "simvastatin"
            ]
          },
          "exception_type": "note",
          "message": "The SLCO1B1 genotype (star nomenclature) will be displayed if determinable with the provided VCF based on the SLCO1B1 star allele definition published by CPIC and recommendations are provided based on the genotype.\u003cbr\u003e\u003cbr\u003eIn case no genotype can be determined, recommendations are based on the rs4149056 genotype alone as per guideline. The minor C allele at rs4149056 defines SLCO1B1*5."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define SLCO1B1 alleles is missing which may change the matched genotype. See the gene section for SLCO1B1 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
        "https://pharmgkb.org/guidelineAnnotation/PA166182844"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
          "authors": [
            "Wilke R A",
            "Ramsey L B",
            "Johnson S G",
            "Maxwell W D",
            "McLeod H L",
            "Voora D",
            "Krauss R M",
            "Roden D M",
            "Feng Q",
            "Cooper-Dehoff R M",
            "Gong L",
            "Klein T E",
            "Wadelius M",
            "Niemi M"
          ],
          "pmid": "22617227",
          "pmcid": "PMC3384438",
          "doi": "10.1038/clpt.2012.57",
          "month": 5,
          "year": 2012
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update",
          "authors": [
            "Ramsey Laura B",
            "Johnson Samuel G",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Voora Deepak",
            "Wilke Russell A",
            "Maxwell Whitney D",
            "McLeod Howard L",
            "Krauss Ronald M",
            "Roden Dan M",
            "Feng Qiping",
            "Cooper-DeHoff Rhonda M",
            "Gong Li",
            "Klein Teri E",
            "Wadelius Mia",
            "Niemi Mikko"
          ],
          "pmid": "24918167",
          "pmcid": "PMC4169720",
          "doi": "10.1038/clpt.2014.125",
          "month": 6,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.",
          "authors": [
            "Cooper-DeHoff Rhonda M",
            "Niemi Mikko",
            "Ramsey Laura B",
            "Luzum Jasmine A",
            "Tarkiainen E Katriina",
            "Straka Robert J",
            "Gong Li",
            "Tuteja Sony",
            "Wilke Russell A",
            "Wadelius Mia",
            "Larson Eric A",
            "Roden Dan M",
            "Klein Teri E",
            "Yee Sook Wah",
            "Krauss Ronald M",
            "Turner Richard M",
            "Palaniappan Latha",
            "Gaedigk Andrea",
            "Giacomini Kathleen M",
            "Caudle Kelly E",
            "Voora Deepak"
          ],
          "pmid": "35152405",
          "pmcid": null,
          "doi": "10.1002/cpt.2557",
          "month": 2,
          "year": 2022
        }
      ],
      "guidelines": [
        {
          "name": "SLCO1B1, ABCG2, CYP2C9, and Statins",
          "id": "RxNorm:36567",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-statins/",
          "annotationGroups": [
            {
              "implications": {
                "SLCO1B1": "Typical myopathy risk and statin exposure"
              },
              "drugRecommendation": "Prescribe desired starting dose and adjust doses based on disease-specific guidelines.",
              "classification": "Strong",
              "phenotypes": {
                "SLCO1B1": "Normal Function"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "SLCO1B1",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "SLCO1B1",
                      "phenotypes": [
                        "Normal Function"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Function"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "The potential for drug-drug interactions and dose limits based on renal and hepatic function and ancestry should be evaluated prior to initiating a statin."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for simvastatin and SLCO1B1",
          "id": "PA166182844",
          "source": "DPWG",
          "version": "10",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182844",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "siponimod",
      "cpicId": null,
      "pharmgkbId": "PA166211021",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166211021"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for siponimod and CYP2C9",
          "id": "PA166211021",
          "source": "DPWG",
          "version": "6",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166211021",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on siponimod."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for siponimod in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "streptomycin",
      "cpicId": "RxNorm:10109",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:10109",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "succinylcholine",
      "cpicId": "RxNorm:10154",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes",
          "authors": [
            "Gonsalves Stephen G",
            "Dirksen Robert T",
            "Sangkuhl Katrin",
            "Pulk Rebecca",
            "Alvarellos Maria",
            "Vo Teresa",
            "Hikino Keiko",
            "Roden Dan",
            "Klein Teri",
            "Mark Poler S",
            "Patel Sephalie",
            "Caudle Kelly E",
            "Gordon Ronald",
            "Brandom Barbara",
            "Biesecker Leslie G"
          ],
          "pmid": "30499100",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "RYR1, CACNA1S and Volatile anesthetic agents and Succinylcholine",
          "id": "RxNorm:10154",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-ryr1-and-cacna1s/",
          "annotationGroups": [
            {
              "implications": {
                "CACNA1S": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).",
                "RYR1": "These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675)."
              },
              "drugRecommendation": "Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.",
              "classification": "Strong",
              "phenotypes": {
                "CACNA1S": "Uncertain Susceptibility",
                "RYR1": "Uncertain Susceptibility"
              },
              "activityScore": {
                "CACNA1S": "n/a",
                "RYR1": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CACNA1S",
                        "name": "Reference",
                        "function": "Normal Function",
                        "reference": true
                      },
                      "gene": "CACNA1S",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "RYR1",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "RYR1",
                      "phenotypes": [
                        "Uncertain Susceptibility"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Uncertain Susceptibility"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "tacrolimus",
      "cpicId": "RxNorm:42316",
      "pharmgkbId": "PA166104983",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104983"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing",
          "authors": [
            "Birdwell Kelly A",
            "Decker Brian",
            "Barbarino Julia M",
            "Peterson Josh F",
            "Stein C Michael",
            "Sadee Wolfgang",
            "Wang Danxin",
            "Vinks Alexander A",
            "He Yijing",
            "Swen Jesse J",
            "Leeder J Steven",
            "van Schaik R H N",
            "Thummel Kenneth E",
            "Klein Teri E",
            "Caudle Kelly E",
            "MacPhee Iain A M"
          ],
          "pmid": "25801146",
          "pmcid": "PMC4481158",
          "doi": "10.1002/cpt.113",
          "month": 3,
          "year": 2015
        }
      ],
      "guidelines": [
        {
          "name": "CYP3A5 and Tacrolimus",
          "id": "RxNorm:42316",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tacrolimus-and-cyp3a5/",
          "annotationGroups": [
            {
              "implications": {
                "CYP3A5": "Lower dose-adjusted trough concentrations of tacrolimus and decreased chance of achieving target tacrolimus concentrations."
              },
              "drugRecommendation": "Increase starting dose 1.5 to 2 times recommended starting dose. Total starting dose should not exceed 0.3 mg/kg/day. Use therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Strong",
              "phenotypes": {
                "CYP3A5": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP3A5": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP3A5",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP3A5",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP3A5",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "This recommendation includes the use of tacrolimus in kidney, heart, lung and hematopoietic stem cell transplant patients, and liver transplant patients where the donor and recipient genotypes are identical. Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors (e.g., medication interactions, or hepatic function). Typically with other CYP enzymes, a normal metabolizer would be classified as having normal metabolism, and therefore, the drug dose would not change based on the patients genotype. However, in the case of CYP3A5 and tacrolimus, a CYP3A5 expresser (i.e., CYP3A5 normal metabolizer or intermediate metabolizer) would require a higher recommended starting dose, and the CYP3A5 non-expresser (i.e., poor metabolizer) would require the standard recommended starting dose."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for tacrolimus and CYP3A5",
          "id": "PA166104983",
          "source": "DPWG",
          "version": "28",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104983",
          "annotationGroups": [
            {
              "implications": {
                "CYP3A5": "An increase of the initial dose can result in an increased chance of reaching a tacrolimus concentration within the target range before the start of therapeutic drug monitoring. However, there is no direct evidence that this results in improved clinical results. The genetic variation results in an increased conversion of tacrolimus to inactive metabolites and therefore a higher required dose."
              },
              "drugRecommendation": "LIVER TRANSPLANTATION\nIn addition to the patients genotype, the metabolism of tacrolimus is also determined by the genotype of the transplanted liver.\nLIVER is also of the genotype HOMOZYGOUS EXPRESSOR: Use 2.5 times the normal initial dose. Adjustment of the dose should then be based on therapeutic drug monitoring.\nLIVER has a DIFFERENT genotype: There is insufficient evidence in the literature to support a dose recommendation.\nOTHER TRANSPLANTATION\nUse 2.5 times the initial dose that would yield the desired result in non-expressers. Adjustment of the dose should then be based on therapeutic drug monitoring. For example: One Dutch study found a median trough concentration for tacrolimus after three days of 9.4 ng/mL at an initial dose of 0.15 mg/kg twice daily for 5 homozygous kidney transplant patients. Their target value was 10 - 15 ng/mL.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP3A5",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP3A5",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP3A5",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "tamoxifen",
      "cpicId": "RxNorm:10324",
      "pharmgkbId": "PA166104966",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104966"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.",
          "authors": [
            "Goetz Matthew P",
            "Sangkuhl Katrin",
            "Guchelaar Henk-Jan",
            "Schwab Matthias",
            "Province Michael",
            "Whirl-Carrillo Michelle",
            "Symmans W Fraser",
            "McLeod Howard L",
            "Ratain Mark J",
            "Zembutsu Hitoshi",
            "Gaedigk Andrea",
            "van Schaik Ron H",
            "Ingle James N",
            "Caudle Kelly E",
            "Klein Teri E"
          ],
          "pmid": "29385237",
          "pmcid": "PMC5931215",
          "doi": "10.1002/cpt.1007",
          "month": 5,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6 and Tamoxifen",
          "id": "RxNorm:10324",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-tamoxifen-based-on-cyp2d6-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Lower endoxifen concentrations compared to normal metabolizers; higher risk of breast cancer recurrence, event-free and recurrence-free survival compared to normal metabolizers."
              },
              "drugRecommendation": "Consider hormonal therapy such as an aromatase inhibitor for postmenopausal women or aromatase inhibitor along with ovarian function suppression in premenopausal women, given that these approaches are superior to tamoxifen regardless of CYP2D6 genotype (PMID 26211827). If aromatase inhibitor use is contraindicated, consideration should be given to use a higher but FDA approved tamoxifen dose (40 mg/day)(PMID 27226358). Avoid CYP2D6 strong to weak inhibitors.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for tamoxifen and CYP2D6",
          "id": "PA166104966",
          "source": "DPWG",
          "version": "24",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104966",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "This gene variation reduces the conversion of tamoxifen to the active metabolite endoxifen. This can result in reduced effectiveness."
              },
              "drugRecommendation": "\u003col\u003e\n\u003cli\u003eSelect an alternative or measure the endoxifen concentration and increase the dose if necessary by a factor of 1.5-2. Aromatase inhibitors are a possible alternative for post-menopausal women.\u003c/li\u003e\n\u003cli\u003eIf TAMOXIFEN is selected: avoid co-medication with CYP2D6 inhibitors such as paroxetine and fluoxetine\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "tegafur",
      "cpicId": null,
      "pharmgkbId": "PA166104944",
      "messages": [],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104944"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for tegafur and DPYD",
          "id": "PA166104944",
          "source": "DPWG",
          "version": "27",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104944",
          "annotationGroups": [
            {
              "implications": {
                "DPYD": "The guideline does not provide a description of the impact of a DPYD activity score of 2 on tegafur."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for tegafur in patients with a DPYD activity score of 2.",
              "classification": "N/A",
              "phenotypes": {},
              "activityScore": {
                "DPYD": "2"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "DPYD",
                        "name": "Reference",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "DPYD",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "Reference/Reference",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "tenoxicam",
      "cpicId": "RxNorm:37790",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.",
          "authors": [
            "Theken Katherine N",
            "Lee Craig R",
            "Gong Li",
            "Caudle Kelly E",
            "Formea Christine M",
            "Gaedigk Andrea",
            "Klein Teri E",
            "Agndez Jos A G",
            "Grosser Tilo"
          ],
          "pmid": "32189324",
          "pmcid": null,
          "doi": "10.1002/cpt.1830",
          "month": 3,
          "year": 2020
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9 and NSAIDs",
          "id": "RxNorm:37790",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-nsaids-based-on-cyp2c9-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "Normal metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for shortest duration consistent with individual patient treatment goals.",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {
                "CYP2C9": "2.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        }
      ]
    },
    {
      "name": "thioguanine",
      "cpicId": "RxNorm:10485",
      "pharmgkbId": "PA166184612",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
        "https://pharmgkb.org/guidelineAnnotation/PA166184612"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Klein T E"
          ],
          "pmid": "21270794",
          "pmcid": "PMC3098761",
          "doi": "10.1038/clpt.2010.320",
          "month": 3,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update",
          "authors": [
            "Relling M V",
            "Gardner E E",
            "Sandborn W J",
            "Schmiegelow K",
            "Pui C-H",
            "Yee S W",
            "Stein C M",
            "Carrillo M",
            "Evans W E",
            "Hicks J K",
            "Schwab M",
            "Klein T E"
          ],
          "pmid": "23422873",
          "pmcid": "PMC3604643",
          "doi": "10.1038/clpt.2013.4",
          "month": 1,
          "year": 2013
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.",
          "authors": [
            "Relling Mary V",
            "Schwab Matthias",
            "Whirl-Carrillo Michelle",
            "Suarez-Kurtz Guilherme",
            "Pui Ching-Hon",
            "Stein Charles M",
            "Moyer Ann M",
            "Evans William E",
            "Klein Teri E",
            "Antillon-Klussmann Federico Guillermo",
            "Caudle Kelly E",
            "Kato Motohiro",
            "Yeoh Allen E J",
            "Schmiegelow Kjeld",
            "Yang Jun J"
          ],
          "pmid": "30447069",
          "pmcid": null,
          "doi": null,
          "month": 11,
          "year": 2018
        }
      ],
      "guidelines": [
        {
          "name": "TPMT, NUDT15 and Thiopurines",
          "id": "RxNorm:10485",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-thiopurines-and-tpmt/",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression",
                "TPMT": "Lower concentrations of TGN metabolites, but note that TGN after thioguanine are 5-10X higher than TGN after mercaptopurine or azathioprine. Normal risk of thiopurine-related leukopenia, neutropenia, myelosuppression."
              },
              "drugRecommendation": "Start with normal starting dose (e.g., 40-60 mg/m2/day) and adjust doses of thioguanine and of other myelosuppressive therapy without any special emphasis on thioguanine. Allow 2 weeks to reach steady-state after each dose adjustment (PMID 20354201, 11037857).",
              "classification": "Strong",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer",
                "TPMT": "Normal Metabolizer"
              },
              "activityScore": {
                "NUDT15": "n/a",
                "TPMT": "n/a"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "TPMT",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "TPMT",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Normal starting doses vary by race/ethnicity and treatment regimens. If standard dose is below normal recommended dose, dose reduction might not be recommended for intermediate metabolizers."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for thioguanine and NUDT15",
          "id": "PA166184612",
          "source": "DPWG",
          "version": "5",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166184612",
          "annotationGroups": [
            {
              "implications": {
                "NUDT15": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on thioguanine."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for thioguanine in normal metabolizers",
              "classification": "N/A",
              "phenotypes": {
                "NUDT15": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "NUDT15",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "NUDT15",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "tobramycin",
      "cpicId": "RxNorm:10627",
      "pharmgkbId": null,
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.",
          "authors": [
            "McDermott John Henry",
            "Wolf Joshua",
            "Hoshitsuki Keito",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Steyger Peter S",
            "Smith Richard J H",
            "Cody Neal",
            "Rodriguez-Antona Cristina",
            "Klein Teri E",
            "Newman William G"
          ],
          "pmid": "34032273",
          "pmcid": null,
          "doi": "10.1002/cpt.2309",
          "month": 5,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "MT-RNR1 and Aminoglycosides",
          "id": "RxNorm:10627",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/cpic-guideline-for-aminoglycosides-and-mt-rnr1/",
          "annotationGroups": [
            {
              "implications": {
                "MT-RNR1": "Very high risk of developing hearing loss if administered an aminoglycoside antibiotic."
              },
              "drugRecommendation": "Avoid aminoglycoside anitbiotics unless the high risk of permanent hearing loss is outweighed by the severity of infection and lack of safe or effective alternative therapies.",
              "classification": "Strong",
              "phenotypes": {
                "MT-RNR1": "increased risk of aminoglycoside-induced hearing loss"
              },
              "activityScore": {},
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "MT-RNR1",
                        "name": "1555A\u003eG",
                        "function": "increased risk of aminoglycoside-induced hearing loss",
                        "reference": false
                      },
                      "allele2": null,
                      "gene": "MT-RNR1",
                      "phenotypes": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "increased risk of aminoglycoside-induced hearing loss"
                      ],
                      "label": "1555A\u003eG",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "If no effective alternative to an aminoglycoside antibiotic is available, evaluate for hearing loss frequently during therapy and ensure that all appropriate precautions are utilized (e.g., lowest possible dose and duration, utilization of therapeutic drug monitoring, hydration, renal function monitoring)."
            }
          ]
        }
      ]
    },
    {
      "name": "tramadol",
      "cpicId": "RxNorm:10689",
      "pharmgkbId": "PA166104959",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104959"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
          "authors": [
            "Crews K R",
            "Gaedigk A",
            "Dunnenberger H M",
            "Klein T E",
            "Shen D D",
            "Callaghan J T",
            "Kharasch E D",
            "Skaar T C"
          ],
          "pmid": "22205192",
          "pmcid": "PMC3289963",
          "doi": "10.1038/clpt.2011.287",
          "month": 12,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
          "authors": [
            "Crews Kristine R",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steve",
            "Klein Teri E",
            "Caudle Kelly E",
            "Haidar Cyrine E",
            "Shen Danny D",
            "Callaghan John T",
            "Sadhasivam Senthilkumar",
            "Prows Cynthia A",
            "Kharasch Evan D",
            "Skaar Todd C"
          ],
          "pmid": "24458010",
          "pmcid": "PMC3975212",
          "doi": "10.1038/clpt.2013.254",
          "month": 1,
          "year": 2014
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
          "authors": [
            "Crews Kristine R",
            "Monte Andrew A",
            "Huddart Rachel",
            "Caudle Kelly E",
            "Kharasch Evan D",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Leeder J Steven",
            "Callaghan John T",
            "Samer Caroline Flora",
            "Klein Teri E",
            "Haidar Cyrine E",
            "Van Driest Sara L",
            "Ruano Gualberto",
            "Sangkuhl Katrin",
            "Cavallari Larisa H",
            "Mller Daniel J",
            "Prows Cynthia A",
            "Nagy Mohamed",
            "Somogyi Andrew A",
            "Skaar Todd C"
          ],
          "pmid": "33387367",
          "pmcid": null,
          "doi": "10.1002/cpt.2149",
          "month": 1,
          "year": 2021
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, OPRM1, COMT, and Opioids",
          "id": "RxNorm:10689",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Reduced O-desmethyltramadol (active metabolite) formation"
              },
              "drugRecommendation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "n/a"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for tramadol and CYP2D6",
          "id": "PA166104959",
          "source": "DPWG",
          "version": "29",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104959",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The genetic variation reduces the conversion of tramadol to a metabolite with a higher activity. This can result in reduced analgesia."
              },
              "drugRecommendation": "It is not possible to provide a recommendation for dose adjustment, because the total analgesic effect changes when the ratio between the mother compound and the active metabolite changes.\n\u003col\u003e\n\u003cli\u003ebe alert to a reduced effectiveness\u003c/li\u003e\n\u003cli\u003ein the case of inadequate effectiveness:\na. try a dose increase\nb. if this does not work: choose an alternative. Do not select codeine, as this is also metabolised by CYP2D6. Morphine is not metabolised by CYP2D6. Oxycodone is metabolised by CYP2D6 to a limited extent, but this does not result in differences in analgesia in patients.\u003c/li\u003e\n\u003cli\u003eif no alternative is selected: advise the patient to report inadequate analgesia\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "trimipramine",
      "cpicId": "RxNorm:10834",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update",
          "authors": [
            "Kevin Hicks J",
            "Sangkuhl Katrin",
            "Swen Jesse J",
            "Ellingrod Vicki L",
            "Mller Daniel J",
            "Shimoda Kazutaka",
            "Bishop Jeffrey R",
            "Kharasch Evan D",
            "Skaar Todd C",
            "Gaedigk Andrea",
            "Dunnenberger Henry M",
            "Klein Teri E",
            "Caudle Kelly E",
            "Stingl Julia C"
          ],
          "pmid": "27997040",
          "pmcid": "PMC5478479",
          "doi": "10.1002/cpt.597",
          "month": 12,
          "year": 2016
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants",
          "authors": [
            "Hicks J K",
            "Swen J J",
            "Thorn C F",
            "Sangkuhl K",
            "Kharasch E D",
            "Ellingrod V L",
            "Skaar T C",
            "Mller D J",
            "Gaedigk A",
            "Stingl J C"
          ],
          "pmid": "23486447",
          "pmcid": "PMC3689226",
          "doi": "10.1038/clpt.2013.2",
          "month": 1,
          "year": 2013
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6, CYP2C19 and Tricyclic Antidepressants",
          "id": "RxNorm:10834",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-tricyclic-antidepressants-and-cyp2d6-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal metabolism of tertiary amines",
                "CYP2D6": "Reduced metabolism of TCAs to less active compounds compared to normal metabolizers; Higher plasma concentrations of active drug will increase the probability of side effects"
              },
              "drugRecommendation": "Consider a 25% reduction of recommended starting dose. Utilize therapeutic drug monitoring to guide dose adjustments.",
              "classification": "Optional",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer",
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2C19": "n/a",
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    },
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Patients may receive an initial low dose of a tricyclic, which is then increased over several days to the recommended steady-state dose. The starting dose in this guideline refers to the recommended steady-state dose. Dosing recommendations only apply to higher initial doses of TCAs for treatment of conditions such as depression. See other considerations for dosing recommendations for conditions where lower initial doses are used, such as neuropathic pain."
            }
          ]
        }
      ]
    },
    {
      "name": "tropisetron",
      "cpicId": "RxNorm:27392",
      "pharmgkbId": null,
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron",
          "authors": [
            "Bell Gillian C",
            "Caudle Kelly E",
            "Whirl-Carrillo Michelle",
            "Gordon Ronald J",
            "Hikino Keiko",
            "Prows Cynthia A",
            "Gaedigk Andrea",
            "Agundez Jose A G",
            "Sadhasivam Senthilkumar",
            "Klein Teri E",
            "Schwab Matthias"
          ],
          "pmid": "28002639",
          "pmcid": "PMC5479760",
          "doi": "10.1002/cpt.598",
          "month": 12,
          "year": 2016
        }
      ],
      "guidelines": [
        {
          "name": "CYP2D6 and Ondansetron and Tropisetron",
          "id": "RxNorm:27392",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-ondansetron-and-tropisetron-and-cyp2d6-genotype/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "Very limited data available for CYP2D6 intermediate metabolizers"
              },
              "drugRecommendation": "Insufficient evidence demonstrating clinical impact based on CYP2D6 genotype. Initiate therapy with recommended starting dose.",
              "classification": "No Recommendation",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "1.0"
              },
              "population": "general",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Drug-drug interactions and other patient characteristics (e.g., age, renal function, and liver function) should be considered when selecting alternative therapy."
            }
          ]
        }
      ]
    },
    {
      "name": "venlafaxine",
      "cpicId": null,
      "pharmgkbId": "PA166104968",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104968"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for venlafaxine and CYP2D6",
          "id": "PA166104968",
          "source": "DPWG",
          "version": "26",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104968",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "There are indications of an increased risk of side effects and a reduced chance of efficacy. The gene variation reduces the conversion of venlafaxine to the active metabolite O-desmethylvenlafaxine, whilst an association between high O-desmethylvenlafaxine/venlafaxine ratios and response without side effects was found."
              },
              "drugRecommendation": "It is not possible to offer adequately substantiated advice for dose reduction based on the literature.\n\u003cul\u003e\n\u003cli\u003eavoid venlafaxine. Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, duloxetine, mirtazapine, citalopram and sertraline.\u003c/li\u003e\n\u003cli\u003eif it is not possible to avoid venlafaxine and side effects occur:\u003c/li\u003e\n\u003c/ul\u003e\n\u003col\u003e\n\u003cli\u003ereduce the dose\u003c/li\u003e\n\u003cli\u003emonitor the effect and side effects or check the plasma concentrations of venlafaxine and O-desmethylvenlafaxine.\nIt is not known whether it is possible to reduce the dose to such an extent that the side effects disappear, while the effectiveness is maintained. In general, it is assumed that the effectiveness is determined by the sum of the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. However, the side effects do not appear to be related to this sum.\u003c/li\u003e\n\u003c/ol\u003e",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    },
    {
      "name": "voriconazole",
      "cpicId": "RxNorm:121243",
      "pharmgkbId": "PA166104990",
      "messages": [],
      "variants": [],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/",
        "https://pharmgkb.org/guidelineAnnotation/PA166104990"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Voriconazole Therapy",
          "authors": [
            "Moriyama Brad",
            "Obeng Aniwaa Owusu",
            "Barbarino Julia",
            "Penzak Scott R",
            "Henning Stacey A",
            "Scott Stuart A",
            "Agndez Jos A G",
            "Wingard John R",
            "McLeod Howard L",
            "Klein Teri E",
            "Cross Shane",
            "Caudle Kelly E",
            "Walsh Thomas J"
          ],
          "pmid": "27981572",
          "pmcid": "PMC5474211",
          "doi": "10.1002/cpt.583",
          "month": 12,
          "year": 2016
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C19 and Voriconazole",
          "id": "RxNorm:121243",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C19": "Normal voriconazole metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended standard of care dosing",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "adults",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities."
            },
            {
              "implications": {
                "CYP2C19": "Normal voriconazole metabolism"
              },
              "drugRecommendation": "Initiate therapy with recommended standard of care dosing",
              "classification": "Strong",
              "phenotypes": {
                "CYP2C19": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "pediatrics",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C19",
                        "name": "*38",
                        "function": "Normal function",
                        "reference": true
                      },
                      "gene": "CYP2C19",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "Normal Metabolizer"
                      ],
                      "label": "*38/*38",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "Further dose adjustments or selection of alternative therapy may be necessary due to other clinical factors, such as drug interactions, hepatic function, renal function, species, site of infection, therapeutic drug monitoring, and comorbidities."
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for voriconazole and CYP2C19",
          "id": "PA166104990",
          "source": "DPWG",
          "version": "24",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104990",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "warfarin",
      "cpicId": "RxNorm:11289",
      "pharmgkbId": "PA166182841",
      "messages": [
        {
          "rule_name": "warfarin figure 2 note",
          "version": "1",
          "matches": {
            "gene": "",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": [
              "warfarin"
            ]
          },
          "exception_type": "note",
          "message": "Please follow the flow chart in figure 2 of the \u003ca href\u003d\"https://www.pharmgkb.org/guideline/PA166104949\"\u003eCPIC warfarin guideline\u003c/a\u003e to determine the appropriate dosing recommendation."
        },
        {
          "rule_name": "Warfarin warning",
          "version": "1",
          "matches": {
            "gene": "",
            "hapsCalled": [],
            "hapsMissing": [],
            "variantsMissing": [],
            "variant": "",
            "dips": [],
            "drugs": [
              "warfarin"
            ]
          },
          "exception_type": "footnote",
          "message": "The CPIC warfarin guideline only considers a single SNV in VKORC1 (rs9923231), which is found in the highest frequency in Caucasians and extremely low frequency in those of African descent. While other functional variants in VKORC1 have been observed in much higher frequencies in some populations, there are currently no CPIC recommendations for how to use these other variants in warfarin dosing. An alternate name for rs9923231 is -1639G\u003eA (note that VKORC1 is on the negative chromosomal strand, so displayed alleles are complemented). "
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        },
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "Some position data used to define CYP2C9 alleles is missing which may change the matched genotype. See the gene section for CYP2C9 for more information."
        }
      ],
      "variants": [
        "rs12777823"
      ],
      "urls": [
        "https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/",
        "https://pharmgkb.org/guidelineAnnotation/PA166182842",
        "https://pharmgkb.org/guidelineAnnotation/PA166182841"
      ],
      "publications": [
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing",
          "authors": [
            "Johnson J A",
            "Gong L",
            "Whirl-Carrillo M",
            "Gage B F",
            "Scott S A",
            "Stein C M",
            "Anderson J L",
            "Kimmel S E",
            "Lee M T M",
            "Pirmohamed M",
            "Wadelius M",
            "Klein T E",
            "Altman R B"
          ],
          "pmid": "21900891",
          "pmcid": "PMC3187550",
          "doi": "10.1038/clpt.2011.185",
          "month": 9,
          "year": 2011
        },
        {
          "journal": "Clinical pharmacology and therapeutics",
          "title": "Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update",
          "authors": [
            "Johnson Julie A",
            "Caudle Kelly E",
            "Gong Li",
            "Whirl-Carrillo Michelle",
            "Stein C Michael",
            "Scott Stuart A",
            "Lee Ming Ta Michael",
            "Gage Brian F",
            "Kimmel Stephen E",
            "Perera Minoli A",
            "Anderson Jeffrey L",
            "Pirmohamed Munir",
            "Klein Teri E",
            "Limdi Nita A",
            "Cavallari Larisa H",
            "Wadelius Mia"
          ],
          "pmid": "28198005",
          "pmcid": "PMC5546947",
          "doi": "10.1002/cpt.668",
          "month": 2,
          "year": 2017
        }
      ],
      "guidelines": [
        {
          "name": "CYP2C9, VKORC1, CYP4F2 and Warfarin",
          "id": "RxNorm:11289",
          "source": "CPIC",
          "version": "v.1.17.1",
          "url": "https://cpicpgx.org/guidelines/guideline-for-warfarin-and-cyp2c9-and-vkorc1/",
          "annotationGroups": []
        },
        {
          "name": "Annotation of DPWG Guideline for warfarin and CYP2C9",
          "id": "PA166182842",
          "source": "DPWG",
          "version": "4",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182842",
          "annotationGroups": [
            {
              "implications": {
                "CYP2C9": "The guideline does not provide a description of the impact of a normal metabolizer phenotype on warfarin."
              },
              "drugRecommendation": "The guideline does not provide a recommendation for warfarin in normal metabolizers.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2C9": "Normal Metabolizer"
              },
              "activityScore": {},
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2C9",
                        "name": "*1",
                        "function": "Normal function (CYP2C9*1)",
                        "reference": true
                      },
                      "gene": "CYP2C9",
                      "phenotypes": [
                        "Normal Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "2"
                      ],
                      "label": "*1/*1",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        },
        {
          "name": "Annotation of DPWG Guideline for warfarin and VKORC1",
          "id": "PA166182841",
          "source": "DPWG",
          "version": "5",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166182841",
          "annotationGroups": []
        }
      ]
    },
    {
      "name": "zuclopenthixol",
      "cpicId": null,
      "pharmgkbId": "PA166104992",
      "messages": [
        {
          "rule_name": null,
          "version": null,
          "matches": null,
          "exception_type": "note",
          "message": "The *1 allele assignment is characterized by the absence of variants that are included in the underlying allele definitions by either position being reference or missing."
        }
      ],
      "variants": [],
      "urls": [
        "https://pharmgkb.org/guidelineAnnotation/PA166104992"
      ],
      "publications": [],
      "guidelines": [
        {
          "name": "Annotation of DPWG Guideline for zuclopenthixol and CYP2D6",
          "id": "PA166104992",
          "source": "DPWG",
          "version": "27",
          "url": "https://pharmgkb.org/guidelineAnnotation/PA166104992",
          "annotationGroups": [
            {
              "implications": {
                "CYP2D6": "The risk of side effects may be elevated. The genetic variation leads to decreased conversion of zuclopentixol, which causes the plasma concentration to be approximately 1.35-fold higher."
              },
              "drugRecommendation": "Use 75% of the standard dose.",
              "classification": "N/A",
              "phenotypes": {
                "CYP2D6": "Intermediate Metabolizer"
              },
              "activityScore": {
                "CYP2D6": "Total gene activity score \u003d 0.5-1"
              },
              "population": "N/A",
              "genotypes": [
                {
                  "diplotypes": [
                    {
                      "allele1": {
                        "gene": "CYP2D6",
                        "name": "*1",
                        "function": "Normal function",
                        "reference": true
                      },
                      "allele2": {
                        "gene": "CYP2D6",
                        "name": "*3",
                        "function": "No function",
                        "reference": false
                      },
                      "gene": "CYP2D6",
                      "phenotypes": [
                        "Intermediate Metabolizer"
                      ],
                      "variant": null,
                      "lookupKey": [
                        "1"
                      ],
                      "label": "*1/*3",
                      "geneResult": null
                    }
                  ]
                }
              ],
              "comments": "N/A"
            }
          ]
        }
      ]
    }
  ]
}